<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Rheumatoid arthritis,Articles with unsourced statements since July 2008,Articles with unsourced statements since August 2008,Articles needing additional references from October 2008,Articles with unsourced statements since February 2009,Fact,Arthropathies and related conditions,Hypersensitivity and autoimmune diseases,Congenital malformations and deformations of musculoskeletal system,123 AD,2007" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Rheumatoid arthritis - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Rheumatoid_arthritis";
		var wgTitle = "Rheumatoid arthritis";
		var wgAction = "view";
		var wgArticleId = "25875";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 283205273;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Rheumatoid_arthritis skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Rheumatoid arthritis</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Rheumatoid arthritis</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><a href="/wiki/File:Rheumatoid_arthritis_joint.gif" class="image" title="Rheumatoid arthritis joint.gif"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/7/7e/Rheumatoid_arthritis_joint.gif" width="190" height="369" border="0" /></a></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>A diagram showing how rheumatoid arthritis affects a joint</small></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_M" title="ICD-10 Chapter M" class="mw-redirect">M</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gm05.htm+m05" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gm05.htm+m05" rel="nofollow">05.</a>-<a href="/wiki/ICD-10_Chapter_M" title="ICD-10 Chapter M" class="mw-redirect">M</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gm05.htm+m06" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gm05.htm+m06" rel="nofollow">06.</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=714" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=714" rel="nofollow">714</a></td>
</tr>
<tr>
<th><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=180300" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=180300" rel="nofollow">180300</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb11506.htm" class="external text" title="http://www.diseasesdatabase.com/ddb11506.htm" rel="nofollow">11506</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000431.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000431.htm" rel="nofollow">000431</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic2024.htm" class="external text" title="http://www.emedicine.com/med/topic2024.htm" rel="nofollow">med/2024</a>&#160; <a href="http://www.emedicine.com/emerg/topic48.htm#" class="external text" title="http://www.emedicine.com/emerg/topic48.htm#" rel="nofollow">emerg/48</a> <a href="http://www.emedicine.com/pmr/topic124.htm#" class="external text" title="http://www.emedicine.com/pmr/topic124.htm#" rel="nofollow">pmr/124</a></td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D001172" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D001172" rel="nofollow">D001172</a></td>
</tr>
</table>
<p><b>Rheumatoid arthritis</b> (<b>RA</b>) is a chronic, <a href="/wiki/Systemic_disease" title="Systemic disease">systemic</a> <a href="/wiki/Inflammation" title="Inflammation">inflammatory disorder</a> that may affect many tissues and organs, but principally attacks the joints producing a inflammatory <a href="/wiki/Synovitis" title="Synovitis">synovitis</a> that often progresses to destruction of the articular cartilage and <a href="/wiki/Ankylosis" title="Ankylosis">ankylosis</a> of the joints. Rheumatoid arthritis can also produce diffuse inflammation in the <a href="/wiki/Lung" title="Lung">lungs</a>, <a href="/wiki/Pericardium" title="Pericardium">pericardium</a>, <a href="/wiki/Pleura" title="Pleura" class="mw-redirect">pleura</a>, and <a href="/wiki/Sclera" title="Sclera">sclera</a>, and also nodular lesions, most common in subcutaneous tissue under the <a href="/wiki/Skin" title="Skin">skin</a>. Although the cause of rheumatoid arthritis is unknown, autoimmunity plays a pivotal role in its chronicity and progression.</p>
<p>About 1% of the world's population is afflicted by rheumatoid arthritis, women three times more often than men. Onset is most frequent in 40 to 50 years, but no age is immune. It can be a disabling and <a href="/wiki/Pain" title="Pain">painful</a> condition, which can lead to substantial loss of functioning and mobility. It is diagnosed chiefly on symptoms and signs, but also with <a href="/wiki/Blood_test" title="Blood test">blood tests</a> (especially a test called <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factor</a>) and <a href="/wiki/Medical_imaging" title="Medical imaging">X-rays</a>. Diagnosis and long-term management are typically performed by a <a href="/wiki/Rheumatology" title="Rheumatology">rheumatologist</a>, an expert in the diseases of joints and connective tissues.<sup id="cite_ref-Majithia2007_0-0" class="reference"><a href="#cite_note-Majithia2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>Various treatments are available. Non-pharmacological treatment includes <a href="/wiki/Physical_therapy" title="Physical therapy">physical therapy</a> and <a href="/wiki/Occupational_therapy" title="Occupational therapy">occupational therapy</a>. <a href="/wiki/Analgesia" title="Analgesia" class="mw-redirect">Analgesia</a> (painkillers) and <a href="/wiki/Anti-inflammatory" title="Anti-inflammatory">anti-inflammatory</a> drugs, as well as <a href="/wiki/Glucocorticoid" title="Glucocorticoid">steroids</a>, are used to suppress the symptoms, while <a href="/wiki/Disease-modifying_antirheumatic_drug" title="Disease-modifying antirheumatic drug">disease-modifying antirheumatic drugs</a> (DMARDs) are often required to inhibit or halt the underlying immune process and prevent long-term damage. In recent times, the newer group of <a href="/wiki/Biologics" title="Biologics">biologics</a> has increased treatment options.<sup id="cite_ref-Majithia2007_0-1" class="reference"><a href="#cite_note-Majithia2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>The name is based on the term "<a href="/wiki/Rheumatic_fever" title="Rheumatic fever">rheumatic fever</a>", an illness which includes joint pain and is derived from the Greek word <i>rheumatos</i> ("flowing"). The suffix -<i>oid</i> ("resembling") gives the translation as <i>joint inflammation that resembles rheumatic fever</i>. The first recognized description of rheumatoid arthritis was made in 1800 by Dr <a href="/wiki/Augustin_Jacob_Landr%C3%A9-Beauvais" title="Augustin Jacob Landré-Beauvais">Augustin Jacob Landré-Beauvais</a> (1772-1840) of Paris.<sup id="cite_ref-Landre1800_1-0" class="reference"><a href="#cite_note-Landre1800-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2"><a href="#Joints"><span class="tocnumber">1.1</span> <span class="toctext">Joints</span></a></li>
<li class="toclevel-2"><a href="#Skin"><span class="tocnumber">1.2</span> <span class="toctext">Skin</span></a></li>
<li class="toclevel-2"><a href="#Lungs"><span class="tocnumber">1.3</span> <span class="toctext">Lungs</span></a></li>
<li class="toclevel-2"><a href="#Kidneys"><span class="tocnumber">1.4</span> <span class="toctext">Kidneys</span></a></li>
<li class="toclevel-2"><a href="#Heart_and_blood_vessels"><span class="tocnumber">1.5</span> <span class="toctext">Heart and blood vessels</span></a></li>
<li class="toclevel-2"><a href="#Other"><span class="tocnumber">1.6</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">2</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2"><a href="#Imaging"><span class="tocnumber">2.1</span> <span class="toctext">Imaging</span></a></li>
<li class="toclevel-2"><a href="#Blood_tests"><span class="tocnumber">2.2</span> <span class="toctext">Blood tests</span></a></li>
<li class="toclevel-2"><a href="#Diagnostic_criteria"><span class="tocnumber">2.3</span> <span class="toctext">Diagnostic criteria</span></a></li>
<li class="toclevel-2"><a href="#Differential_diagnosis"><span class="tocnumber">2.4</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">4</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Disease_modifying_anti-rheumatic_drugs_.28DMARDs.29"><span class="tocnumber">4.1</span> <span class="toctext">Disease modifying anti-rheumatic drugs (DMARDs)</span></a>
<ul>
<li class="toclevel-3"><a href="#Traditional_small_molecular_mass_drugs"><span class="tocnumber">4.1.1</span> <span class="toctext">Traditional small molecular mass drugs</span></a></li>
<li class="toclevel-3"><a href="#Biological_agents"><span class="tocnumber">4.1.2</span> <span class="toctext">Biological agents</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Anti-inflammatory_agents_and_analgesics"><span class="tocnumber">4.2</span> <span class="toctext">Anti-inflammatory agents and analgesics</span></a></li>
<li class="toclevel-2"><a href="#Other_therapies"><span class="tocnumber">4.3</span> <span class="toctext">Other therapies</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">5</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2"><a href="#Disability"><span class="tocnumber">5.1</span> <span class="toctext">Disability</span></a></li>
<li class="toclevel-2"><a href="#Prognostic_factors"><span class="tocnumber">5.2</span> <span class="toctext">Prognostic factors</span></a></li>
<li class="toclevel-2"><a href="#Mortality"><span class="tocnumber">5.3</span> <span class="toctext">Mortality</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">7</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2"><a href="#Notable_cases"><span class="tocnumber">7.1</span> <span class="toctext">Notable cases</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">8</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<p>While rheumatoid arthritis primarily affects joints, problems involving other organs of the body are known to occur. Extra-articular ("outside the joints") manifestations other than anemia (which is very common) are clinically evident in about 15-25% of individuals with rheumatoid arthritis.<sup id="cite_ref-pmid12860726_2-0" class="reference"><a href="#cite_note-pmid12860726-2" title=""><span>[</span>3<span>]</span></a></sup> It can be difficult to determine whether disease manifestations are directly caused by the rheumatoid process itself, or from side effects of the medications commonly used to treat it - for example, lung fibrosis from <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> or <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> from corticosteroids.</p>
<p><a name="Joints" id="Joints"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=2" title="Edit section: Joints">edit</a>]</span> <span class="mw-headline">Joints</span></h3>
<p>The arthritis of rheumatoid arthritis is due to <a href="/wiki/Synovitis" title="Synovitis">synovitis</a>, which is inflammation of the <a href="/wiki/Synovial_membrane" title="Synovial membrane">synovial membrane</a> that lines joints and tendon sheaths. Joints become swollen, tender and warm, and stiffness limits their movement. With time, RA nearly always affects multiple joints (it is a <a href="/wiki/Polyarthritis" title="Polyarthritis">polyarthritis</a>). Most commonly, small joints of the <a href="/wiki/Hands" title="Hands" class="mw-redirect">hands</a>, <a href="/wiki/Feet" title="Feet" class="mw-redirect">feet</a> and <a href="/wiki/Cervical_spine" title="Cervical spine" class="mw-redirect">cervical spine</a> are affected, but larger joints like the shoulder and knee can also be involved, differing per individual. Synovitis can lead to tethering of tissue with loss of movement and erosion of the joint surface, causing deformity and loss of function.<sup id="cite_ref-Majithia2007_0-2" class="reference"><a href="#cite_note-Majithia2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>Rheumatoid arthritis typically manifests with signs of inflammation, and the affected joints are swollen, warm, painful and stiff early in the morning on waking or following prolonged inactivity. Increased stiffness early in the morning is often a prominent feature of the inflammatory disease which the person may experience and may last for more than an hour. Gentle movements may relieve symptoms in early stages of the disease. These signs help distinguish rheumatoid from non-inflammatory problems of the joints, often referred to as <a href="/wiki/Osteoarthritis" title="Osteoarthritis">osteoarthritis</a> or "wear-and-tear" arthritis. In arthritis of non-inflammatory causes, signs of inflammation and early morning stiffness are absent and also movements aggravate pain due to the wear-and-tear.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup> In RA, the joints are often affected in a fairly symmetrical fashion, although this is not specific, and the initial presentation may be asymmetrical.</p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Arthrite_rhumatoide.jpg" class="image" title="Hands affected by RA"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3a/Arthrite_rhumatoide.jpg/180px-Arthrite_rhumatoide.jpg" width="180" height="79" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Arthrite_rhumatoide.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Hands affected by RA</div>
</div>
</div>
<p>As the pathology progresses, the inflammatory activity leads to tendon tethering and erosion and destruction of the joint surface, which impairs range of movement and leads to deformity. The fingers may suffer from almost any deformity, depending on which joints are most involved. Medical students are taught to learn names for specific deformities, such as <i><a href="/wiki/Ulnar_deviation" title="Ulnar deviation">ulnar deviation</a></i>, <a href="/wiki/Boutonniere_deformity" title="Boutonniere deformity">boutonniere deformity</a>, <a href="/wiki/Swan_neck_deformity" title="Swan neck deformity">swan neck deformity</a> and "Z-thumb" but these are of no more significance to diagnosis or disability than other variants.</p>
<p><a name="Skin" id="Skin"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=3" title="Edit section: Skin">edit</a>]</span> <span class="mw-headline">Skin</span></h3>
<p>The <i><a href="/wiki/Rheumatoid_nodule" title="Rheumatoid nodule">rheumatoid nodule</a></i>, which is often subcutaneous, is the feature most characteristic of rheumatoid arthritis. The initial pathologic process in nodule formation is unknown but may be essentially the same as the synovitis, since similar structural features occur in both. The nodule has a central area of <a href="/wiki/Fibrinoid_necrosis" title="Fibrinoid necrosis">fibrinoid necrosis</a> that may be fissured and which corresponds to the fibrin-rich necrotic material found in and around an affected synovial space. Surrounding the necrosis is a layer of palisading <a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a> and <a href="/wiki/Fibroblasts" title="Fibroblasts" class="mw-redirect">fibroblasts</a>, corresponding to the intimal layer in synovium and a cuff of <a href="/wiki/Connective_tissue" title="Connective tissue">connective tissue</a> containing clusters of lymphocytes and plasma cells, corresponding to the subintimal zone in synovitis. The typical rheumatoid nodule may be a few millimetres to a few centimetres in diameter and is usually found over bony prominences, such as the <a href="/wiki/Olecranon" title="Olecranon">olecranon</a>, the <a href="/wiki/Calcaneus#Calcaneal_tuberosity" title="Calcaneus">calcaneal tuberosity</a>, the metacarpophalangeal joints, or other areas that sustain repeated mechanical stress. Nodules are associated with a positive RF (rheumatoid factor) titer and severe erosive arthritis. Rarely, these can occur in internal organs.</p>
<p>Several forms of <i><a href="/wiki/Vasculitis" title="Vasculitis">vasculitis</a></i> occur in rheumatoid arthritis. A benign form occurs as microinfarcts around the nailfolds. More severe forms include <a href="/wiki/Livedo_reticularis" title="Livedo reticularis">livedo reticularis</a>, which is a network (reticulum) of erythematous to purplish discoloration of the skin due to the presence of an obliterative cutaneous capillaropathy.</p>
<p>Other, rather rare, skin associated symtoms include:</p>
<ul>
<li><a href="/wiki/Pyoderma_gangrenosum" title="Pyoderma gangrenosum">pyoderma gangrenosum</a>, a necrotizing, ulcerative, noninfectious neutrophilic dermatosis.</li>
<li><a href="/wiki/Sweet%27s_syndrome" title="Sweet's syndrome">Sweet's syndrome</a>, a neutrophilic dermatosis usually associated with myeloproliferative disorders</li>
<li>drug reactions</li>
<li><a href="/wiki/Erythema_nodosum" title="Erythema nodosum">erythema nodosum</a></li>
<li>lobular <a href="/wiki/Panniculitis" title="Panniculitis">panniculitis</a></li>
<li><a href="/wiki/Atrophy" title="Atrophy">atrophy</a> of digital skin</li>
<li><a href="/wiki/Palmar_erythema" title="Palmar erythema">palmar erythema</a></li>
<li>diffuse thinning (rice paper skin), and skin fragility (often worsened by corticosteroid use).</li>
</ul>
<p><a name="Lungs" id="Lungs"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=4" title="Edit section: Lungs">edit</a>]</span> <span class="mw-headline">Lungs</span></h3>
<p><a href="/wiki/Fibrosis" title="Fibrosis">Fibrosis</a> of the <a href="/wiki/Lungs" title="Lungs" class="mw-redirect">lungs</a> is a recognised response to rheumatoid disease. It is also a rare but well recognised consequence of therapy (for example with methotrexate and <a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a>). <a href="/wiki/Caplan%27s_syndrome" title="Caplan's syndrome">Caplan's syndrome</a> describes lung nodules in individuals with rheumatoid arthritis and additional exposure to <a href="/wiki/Coal" title="Coal">coal</a> dust. <a href="/wiki/Pleural_effusion" title="Pleural effusion">Pleural effusions</a> are also associated with rheumatoid arthritis.</p>
<p><a name="Kidneys" id="Kidneys"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=5" title="Edit section: Kidneys">edit</a>]</span> <span class="mw-headline">Kidneys</span></h3>
<p>Renal <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a> can occur as a consequence of chronic inflammation. <sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup> Rheumatoid arthritis may affect the kidney glomerulus directly through a vasculopathy or a mesangial infiltrate but this is less well documented. Treatment with <a href="/wiki/Penicillamine" title="Penicillamine">Penicillamine</a> and <a href="/wiki/Gold_salts" title="Gold salts">gold salts</a> are recognized causes of <a href="/wiki/Membranous_nephropathy" title="Membranous nephropathy" class="mw-redirect">membranous nephropathy</a>.</p>
<p><a name="Heart_and_blood_vessels" id="Heart_and_blood_vessels"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=6" title="Edit section: Heart and blood vessels">edit</a>]</span> <span class="mw-headline">Heart and blood vessels</span></h3>
<p>People with rheumatoid arthritis are more prone to <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>, and risk of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> (heart attack) and <a href="/wiki/Stroke" title="Stroke">stroke</a> is markedly increased.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> Other possible complications that may arise include: <a href="/wiki/Pericarditis" title="Pericarditis">pericarditis</a>, <a href="/wiki/Endocarditis" title="Endocarditis">endocarditis</a>, left ventricular failure, valvulitis and <a href="/wiki/Fibrosis" title="Fibrosis">fibrosis</a>.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> exercise is always important for all heart problems, but should be gentle.</p>
<p><a name="Other" id="Other"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=7" title="Edit section: Other">edit</a>]</span> <span class="mw-headline">Other</span></h3>
<dl>
<dt>Ocular</dt>
<dd>The eye is directly affected in the form of <a href="/wiki/Episcleritis" title="Episcleritis" class="mw-redirect">episcleritis</a> which when severe can very rarely progress to perforating <a href="/w/index.php?title=Scleromalacia&amp;action=edit&amp;redlink=1" class="new" title="Scleromalacia (page does not exist)">scleromalacia</a>. Rather more common is the indirect effect of <a href="/wiki/Keratoconjunctivitis_sicca" title="Keratoconjunctivitis sicca">keratoconjunctivitis sicca</a>, which is a dryness of eyes and mouth due to lymphocyte infiltration of lachrymal and salivary glands. When severe, dryness of the cornea can lead to keratitis and loss of vision. Preventive treatment of severe dryness with measures such as <a href="/wiki/Nasolacrimal_duct" title="Nasolacrimal duct">nasolacrimal duct</a> occlusion is important.</dd>
</dl>
<dl>
<dt>Hepatic</dt>
<dd>Cytokine production in joints and/or hepatic <a href="/wiki/Kupffer_cells" title="Kupffer cells" class="mw-redirect">Kupffer cells</a> leads to increased activity of hepatocytes with increased production of acute-phase proteins, such as C-reactive protein, and increased release of enzymes such as alkaline phosphatase into the blood. In Felty's syndrome, Kuppfer cell activation is so marked that the resulting increase in hepatocyte activity is associated with nodular hyperplasia of the liver, which may be palpably enlarged. Because Kuppfer cells are not within the liver parenchyma, there is little or no evidence of hepatitis. Hepatic involvement in RA is essentially asymptomatic.</dd>
</dl>
<dl>
<dt>Hematological</dt>
<dd><a href="/wiki/Anemia" title="Anemia">Anemia</a> is by far the commonest abnormality of the blood cells. The red cells are of normal size and colour (normocytic). A low white blood cell count (<a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a>) or usually only occurs in patients with Felty's syndrome with an enlarged liver and spleen. The mechanism of neutropenia is complex. An increased platelet count (<a href="/wiki/Thrombocytosis" title="Thrombocytosis">thrombocytosis</a>) occurs when inflammation is uncontrolled, as does the anemia.</dd>
</dl>
<dl>
<dt>Neurological</dt>
<dd><a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">Peripheral neuropathy</a> and <a href="/wiki/Mononeuritis_multiplex" title="Mononeuritis multiplex">mononeuritis multiplex</a> may occur. The most common problem is carpal tunnel syndrome due to compression of the median nerve by swelling around the wrist. <a href="/w/index.php?title=Atlanto-axial_subluxation&amp;action=edit&amp;redlink=1" class="new" title="Atlanto-axial subluxation (page does not exist)">Atlanto-axial subluxation</a> can occur, owing to erosion of the odontoid process and or/transverse ligaments in the cervical spine's connection to the skull. Such an erosion (&gt;3mm) can give rise to vertebrae slipping over one another and compressing the spinal cord. Clumsiness is initially experienced, but without due care this can progress to <a href="/wiki/Quadriplegia" title="Quadriplegia">quadriplegia</a>.</dd>
</dl>
<dl>
<dt>Constitutional symptoms</dt>
<dd>Constitutional symptoms including fatigue, low grade fever, malaise, morning stiffness, loss of appetite and loss of weight are common systemic manifestations seen in patients with active rheumatoid arthritis.</dd>
</dl>
<dl>
<dt>Osteoporosis</dt>
<dd>Local <a href="/wiki/Osteoporosis" title="Osteoporosis">Osteoporosis</a> occurs in RA around inflamed joints. It is postulated to be partially caused by inflammatory cytokines. More general osteoporosis is probably contributed to by immobility, systemic cytokine effects, local cytokine release in bone marrow and corticosteroid therapy.</dd>
</dl>
<dl>
<dt>Lymphoma</dt>
<dd>The incidence of <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a> is increased in RA, although it is still uncommon.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></dd>
</dl>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=8" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p><a name="Imaging" id="Imaging"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=9" title="Edit section: Imaging">edit</a>]</span> <span class="mw-headline">Imaging</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:RheumatoideArthritisAP.jpg" class="image" title="X-ray of the hand in rheumatoid arthritis."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3e/RheumatoideArthritisAP.jpg/180px-RheumatoideArthritisAP.jpg" width="180" height="298" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:RheumatoideArthritisAP.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
X-ray of the hand in rheumatoid arthritis.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" class="image" title="Signs of destruction and inflammation on ultrasonography and magnetic resonance imaging in the second metacarpophalangeal joint in established rheumatoid arthritis. Thin arrows indicate an erosive change; thick arrows indicate synovitis. Ultrasonography (left side of image) in the (a) longitudinal and (b) the transverse planes shows both signs of destruction and inflammation. Axial T1-weighted magnetic resonance images were obtained (c) before and (d) after contrast administration, also demonstrating synovitis. Additionally, a coronal T1-weighted magnetic resonance image (e) before contrast administration visualizes the same bone erosion as shown in panels c and d."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/0/09/Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" width="180" height="260" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Signs of destruction and inflammation on <a href="/wiki/Medical_ultrasound" title="Medical ultrasound" class="mw-redirect">ultrasonography</a> and <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> in the second <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joint</a> in established rheumatoid arthritis. Thin arrows indicate an erosive change; thick arrows indicate <a href="/wiki/Synovitis" title="Synovitis">synovitis</a>. Ultrasonography (left side of image) in the (a) longitudinal and (b) the transverse planes shows both signs of destruction and inflammation. Axial T1-weighted magnetic resonance images were obtained (c) before and (d) after contrast administration, also demonstrating synovitis. Additionally, a coronal T1-weighted magnetic resonance image (e) before contrast administration visualizes the same bone erosion as shown in panels c and d.</div>
</div>
</div>
<p><a href="/wiki/X-ray" title="X-ray">X-rays</a> of the hands and feet are generally performed in people with a polyarthritis. In rheumatoid arthritis, these may not show any changes in the early stages of the disease, but more advanced cases demonstrate erosions and bone resorption. X-rays of other joints may be taken if symptoms of pain or swelling occur in those joints.</p>
<p>Other medical imaging techniques such as magnetic resonance imaging and ultrasound are also used in rheumatoid arthritis.</p>
<p><a name="Blood_tests" id="Blood_tests"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=10" title="Edit section: Blood tests">edit</a>]</span> <span class="mw-headline">Blood tests</span></h3>
<p>When RA is clinically suspected, <a href="/wiki/Immunology" title="Immunology">immunological</a> studies are required, such as testing for the presence of rheumatoid factor (RF, a specific <a href="/wiki/Antibody" title="Antibody">antibody</a>).<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup> A negative RF does not rule out RA; rather, the arthritis is called <i><a href="/wiki/Seronegative" title="Seronegative" class="mw-redirect">seronegative</a></i>. This is the case in about 15% of patients.<sup id="cite_ref-Nishimura_7-0" class="reference"><a href="#cite_note-Nishimura-7" title=""><span>[</span>8<span>]</span></a></sup> During the first year of illness, rheumatoid factor is more likely to be negative with some individuals converting to seropositive status over time. RF is also seen in other illnesses, for example <a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a>, and in approximately 10% of the healthy population, therefore the test is not very specific.</p>
<p>Because of this low <a href="/wiki/Specificity_(tests)" title="Specificity (tests)" class="mw-redirect">specificity</a>, a new serological test has been developed, which tests for the presence of so called <a href="/wiki/Anti-citrullinated_protein_antibodies" title="Anti-citrullinated protein antibodies" class="mw-redirect">anti-citrullinated protein antibodies</a> (ACPAs). Like RF, this test is positive in only a proportion (67%) of all RA cases, but is rarely positive if RA is not present, giving it a specificity of around 95%.<sup id="cite_ref-Nishimura_7-1" class="reference"><a href="#cite_note-Nishimura-7" title=""><span>[</span>8<span>]</span></a></sup> As with RF, there is evidence for ACPAs being present in many cases even before onset of clinical disease.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Currently, the most common test for ACPAs is the anti-CCP (<a href="/wiki/Cyclic_citrullinated_peptide" title="Cyclic citrullinated peptide" class="mw-redirect">cyclic citrullinated peptide</a>) test.</p>
<p>Also, several other blood tests are usually done to allow for other causes of arthritis, such as <a href="/wiki/Lupus_erythematosus" title="Lupus erythematosus">lupus erythematosus</a>. The <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a> (ESR), <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a>, <a href="/wiki/Full_blood_count" title="Full blood count" class="mw-redirect">full blood count</a>, <a href="/wiki/Renal_function" title="Renal function">renal function</a>, <a href="/wiki/Liver_enzyme" title="Liver enzyme" class="mw-redirect">liver enzymes</a> and other immunological tests (e.g. <a href="/wiki/Antinuclear_antibody" title="Antinuclear antibody" class="mw-redirect">antinuclear antibody</a>/ANA) are all performed at this stage. Elevated <a href="/wiki/Ferritin" title="Ferritin">ferritin</a> levels can reveal <a href="/wiki/Hemochromatosis" title="Hemochromatosis" class="mw-redirect">hemochromatosis</a>, a mimic RA, or be a sign of <a href="/wiki/Still%27s_disease" title="Still's disease">Still's disease</a>, a seronegative, usually juvenile, variant of rheumatoid.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Diagnostic_criteria" id="Diagnostic_criteria"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=11" title="Edit section: Diagnostic criteria">edit</a>]</span> <span class="mw-headline">Diagnostic criteria</span></h3>
<p>The <a href="/wiki/American_College_of_Rheumatology" title="American College of Rheumatology">American College of Rheumatology</a> has defined (1987) the following criteria for the classification of rheumatoid arthritis:<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<ul>
<li>Morning stiffness of &gt;1 hour most mornings for at least 6 weeks.</li>
<li>Arthritis and soft-tissue swelling of &gt;3 of 14 joints/<a href="/wiki/Joint_group" title="Joint group" class="mw-redirect">joint groups</a>, present for at least 6 weeks</li>
<li>Arthritis of hand joints, present for at least 6 weeks</li>
<li>Symmetric arthritis, present for at least 6 weeks</li>
<li>Subcutaneous nodules in specific places</li>
<li><a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">Rheumatoid factor</a> at a level above the 95th percentile</li>
<li>Radiological changes suggestive of joint erosion</li>
</ul>
<p>At least four criteria have to be met for classification as RA. These criteria are not intended for the diagnosis for routine clinical care; they were primarily intended to categorize research. For example: one of the criteria is the presence of bone erosion on X-Ray. Prevention of bone erosion is one of the main aims of treatment because it is generally irreversible. To wait until all of the ACR criteria for rheumatoid arthritis are met may sometimes result in a worse outcome. Most sufferers and rheumatologists would agree that it would be better to treat the condition as early as possible and prevent bone erosion from occurring, even if this means treating people who don't fulfill the ACR criteria. The ACR criteria are, however, very useful for categorising established rheumatoid arthritis, for example for epidemiological purposes.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Differential_diagnosis" id="Differential_diagnosis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=12" title="Edit section: Differential diagnosis">edit</a>]</span> <span class="mw-headline">Differential diagnosis</span></h3>
<p>Several other medical conditions can resemble RA, and usually need to be distinguished from it at the time of diagnosis:<sup id="cite_ref-Merckmanual_9-0" class="reference"><a href="#cite_note-Merckmanual-9" title=""><span>[</span>10<span>]</span></a></sup></p>
<ul>
<li>Crystal induced arthritis (<a href="/wiki/Gout" title="Gout">gout</a>, and <a href="/wiki/Pseudogout" title="Pseudogout" class="mw-redirect">pseudogout</a>) - usually involves particular joints and can be distinguished with aspiration of joint fluid if in doubt</li>
<li><a href="/wiki/Osteoarthritis" title="Osteoarthritis">Osteoarthritis</a> - distinguished with <a href="/wiki/X-ray" title="X-ray">X-rays</a> of the affected joints and blood tests</li>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a> (SLE) - distinguished by specific clinical symptoms and blood tests (antibodies against double-stranded DNA)</li>
<li>One of the several types of <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a> resembles RA - nail changes and skin symptoms distinguish between them</li>
<li><a href="/wiki/Lyme_disease" title="Lyme disease">Lyme disease</a> causes erosive arthritis and may closely resemble RA - it may be distinguished by blood test in endemic areas</li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a> (previously Reiter's disease) - asymmetrically involves heel, <a href="/wiki/Sacroiliac" title="Sacroiliac" class="mw-redirect">sacroiliac</a> joints, and large joints of the leg. It is usually associated with <a href="/wiki/Urethritis" title="Urethritis">urethritis</a>, <a href="/wiki/Conjunctivitis" title="Conjunctivitis">conjunctivitis</a>, <a href="/wiki/Iritis" title="Iritis">iritis</a>, painless buccal ulcers, and <a href="/wiki/Keratoderma_blennorrhagica" title="Keratoderma blennorrhagica">keratoderma blennorrhagica</a>.</li>
<li><a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">Ankylosing spondylitis</a> - this involves the spine and is usually diagnosed in males, although a RA-like symmetrical small-joint polyarthritis may occur in the context of this condition.</li>
</ul>
<p>Rarer causes that usually behave differently but may cause joint pains:<sup id="cite_ref-Merckmanual_9-1" class="reference"><a href="#cite_note-Merckmanual-9" title=""><span>[</span>10<span>]</span></a></sup></p>
<ul>
<li><a href="/wiki/Sarcoidosis" title="Sarcoidosis">Sarcoidosis</a>, amyloidosis, and <a href="/wiki/Whipple%27s_disease" title="Whipple's disease">Whipple's disease</a> can also resemble RA.</li>
<li><a href="/wiki/Hemochromatosis" title="Hemochromatosis" class="mw-redirect">Hemochromatosis</a> may cause hand joint arthritis.</li>
<li>Acute rheumatic fever can be differentiated from RA by a migratory pattern of joint involvement and evidence of antecedent <a href="/wiki/Streptococcal" title="Streptococcal" class="mw-redirect">streptococcal</a> infection. Bacterial arthritis (such as streptococcus) is usually asymmetric, while RA usually involves both sides of the body symmetrically.</li>
<li><a href="/wiki/Gonococcal" title="Gonococcal" class="mw-redirect">Gonococcal</a> arthritis (another bacterial arthritis) is also initially migratory and can involve <a href="/wiki/Tendons" title="Tendons" class="mw-redirect">tendons</a> around the wrists and ankles.</li>
</ul>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=13" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Rheumatoid_arthritis_joint.gif" class="image" title="Joint abnormalities in rheumatoid arthritis"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/7/7e/Rheumatoid_arthritis_joint.gif" width="180" height="349" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Rheumatoid_arthritis_joint.gif" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Joint abnormalities in rheumatoid arthritis</div>
</div>
</div>
<p>Rheumatoid arthritis is a form of <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a>, the causes of which are still incompletely known. It is a systemic (whole body) disorder principally affecting synovial tissues.</p>
<p>The key pieces of evidence relating to pathogenesis are:</p>
<p>1. A genetic link with <a href="/wiki/HLA-DR4" title="HLA-DR4">HLA-DR4</a> and related allotypes of MHC Class II and the T cell-associated protein PTPN22.</p>
<p>2. A link with cigarette smoking that appears to be causal.</p>
<p>3. A dramatic response in many cases to blockade of the cytokine TNF (alpha).</p>
<p>4. A similar dramatic response in many cases to depletion of B lymphocytes, but no comparable response to depletion of T lymphocytes.</p>
<p>5. A more or less random pattern of whether and when predisposed individuals are affected.</p>
<p>6. The presence of autoantibodies to IgGFc, known as rheumatoid factors (RF), and antibodies to citrullinated peptides (ACPA).</p>
<p>These data suggest that the disease involves abnormal B cell - T cell interaction, with presentation of antigens by B cells to T cells via HLA-DR eliciting T cell help and consequent production of RF and ACPA. Inflammation is then driven either by B cell or T cell products stimulating release of TNF and other cytokines. The process may be facilitated by an effect of smoking on citrullination but the stochastic (random) epidemiology suggests that the rate limiting step in genesis of disease in predisposed individuals may be an inherent stochastic process within the immune response such as immunoglobulin or T cell receptor gene recombination and mutation. (See entry under <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a> for general mechanisms.)</p>
<p>If TNF release is stimulated by B cell products in the form of RF or ACPA - containing immune complexes, through activation of immunoglobulin Fc receptors, then RA can be seen as a form of <a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III hypersensitivity</a>.<sup id="cite_ref-urlSUNY_Stony_Brook_Pathology_Department_HBP310_Immunology_10-0" class="reference"><a href="#cite_note-urlSUNY_Stony_Brook_Pathology_Department_HBP310_Immunology-10" title=""><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-urlHypersensitivity_reactions_11-0" class="reference"><a href="#cite_note-urlHypersensitivity_reactions-11" title=""><span>[</span>12<span>]</span></a></sup> If TNF release is stimulated by T cell products such as interleukin-17 it might be considered closer to <a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">type IV hypersensitivity</a> although this terminology may be getting somewhat dated and unhelpful.<sup id="cite_ref-urlLecture_14:_Hypersensitivity_12-0" class="reference"><a href="#cite_note-urlLecture_14:_Hypersensitivity-12" title=""><span>[</span>13<span>]</span></a></sup> The debate on the relative roles of immune complexes and T cell products in inflammation in RA has continued for 30 years. There is little doubt that both B and T cells are essential to the disease. However, there is good evidence for neither cell being necessary at the site of inflammation. This tends to favour immune complexes (based on antibody synthesised elsewhere) as the initiators, even if not the sole perpetuators of inflammation. Moreover, work by Thurlings and others in Paul-Peter Tak's group and also by Arthur Kavanagh's group suggest that if any immune cells are relevant locally they are the plasma cells, which derive from B cells and produce in bulk the antibodies selected at the B cell stage.</p>
<p>Although TNF appears to be the dominant, other <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a> (chemical mediators) are likely to be involved in inflammation in RA. Blockade of TNF does not benefit all patients or all tissues (lung disease and nodules may get worse). Blockade of IL-1, IL-15 and IL-6 also have beneficial effects and IL-17 may be important. Constitutional symptoms such as fever, malaise, loss of appetite and weight loss are also due to cytokines released in to the blood stream.</p>
<p>As with most autoimmune disease, it is important to distinguish between the cause(s) that trigger the process, and those that may permit it to persist and progress.</p>
<p>It has long been suspected that certain infections could be triggers for this disease. The "mistaken identity" theory suggests that an infection triggers an immune response, leaving behind antibodies that should be specific to that organism. The antibodies are not sufficiently specific, though, and set off an immune attack against part of the host. Because the normal host molecule "looks like" a molecule on the offending organism that triggered the initial immune reaction - this phenomenon is called <a href="/wiki/Molecular_mimicry" title="Molecular mimicry">molecular mimicry</a>. Some infectious organisms suspected of triggering rheumatoid arthritis include <i><a href="/wiki/Mycoplasma" title="Mycoplasma">Mycoplasma</a></i>, <i><a href="/wiki/Erysipelothrix" title="Erysipelothrix" class="mw-redirect">Erysipelothrix</a></i>, <a href="/wiki/Parvovirus" title="Parvovirus">parvovirus B19</a> and <a href="/wiki/Rubella" title="Rubella">rubella</a>, <i>but these associations have never been supported in epidemiological studies</i>. Nor has convincing evidence been presented for other types of triggers such as food allergies.</p>
<p>There is also no clear evidence that physical and emotional effects, stress and improper diet could be a trigger for the disease. The many negative findings suggest that either the trigger varies, or that it might in fact be a chance event inherent with the immune response, as suggested by Edwards et al <sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup>.</p>
<p>Epidemiological studies have confirmed a potential association between RA and two <a href="/wiki/Herpesvirus" title="Herpesvirus" class="mw-redirect">herpesvirus</a> infections: <a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus">Epstein-Barr virus</a> (EBV) and <a href="/wiki/Human_Herpesvirus_Six" title="Human Herpesvirus Six" class="mw-redirect">Human Herpes Virus 6</a> (HHV-6). <sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> Individuals with RA are more likely to exhibit an abnormal immune response to the Epstein-Barr virus. <sup id="cite_ref-Ferrell_15-0" class="reference"><a href="#cite_note-Ferrell-15" title=""><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup> The allele HLA-DRB1*0404 is associated with low frequencies of <a href="/wiki/T_cells" title="T cells" class="mw-redirect">T cells</a> specific for the EBV <a href="/wiki/Glycoprotein" title="Glycoprotein">glycoprotein</a> 110 and predisposes one to develop RA.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p>The factors that allow an abnormal immune response, once initiated, to become permanent and chronic, are becoming more clearly understood. The genetic association with HLA-DR4, as well as the newly discovered associations with the gene PTPN22 and with two additional genes <sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup>, all implicate altered thresholds in regulation of the adaptive immune response. It has also become clear from recent studies that these genetic factors may interact with the most clearly defined environmental risk factor for rheumatoid arthritis, namely cigarette smoking <sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup> Other environmental factors also appear to modulate the risk of acquiring RA, and hormonal factors in the individual may explain some features of the disease, such as the higher occurrence in women, the not-infrequent onset after child-birth, and the (slight) modulation of disease risk by hormonal medications. Exactly how altered regulatory thresholds allow the triggering of a specific autoimmune response remains uncertain. However, one possibility is that negative feedback mechanisms that normally maintain tolerance of self are overtaken by aberrant positive feedback mechanisms for certain antigens such as IgG Fc (bound by RF) and citrullinated fibrinogen (bound by ACPA) (see entry on <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a>).</p>
<p>Once the abnormal immune response has become established (which may take several years before any symptoms occur), plasma cells derived from B lymphocytes produce rheumatoid factors and ACPA of the IgG and IgM classes in large quantities. These are not deposited in the way that they are in systemic lupus. Rather, they appear to activate macrophages through Fc receptor and perhaps complement binding. This can contribute to inflammation of the synovium, in terms of edema, vasodilation and infiltration by activated T-cells (mainly CD4 in nodular aggregates and CD8 in diffuse infiltrates). Synovial macrophages and dendritic cells further function as antigen presenting cells by expressing MHC class II molecules, leading to an established local immune reaction in the tissue. The disease progresses in concert with formation of granulation tissue at the edges of the synovial lining (<a href="/wiki/Pannus" title="Pannus">pannus</a>) with extensive angiogenesis and production of enzymes that cause tissue damage. Modern pharmacological treatments of RA target these mediators. Once the inflammatory reaction is established, the synovium thickens, the cartilage and the underlying bone begins to disintegrate and evidence of joint destruction accrues.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=14" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>There is no known cure for rheumatoid arthritis, but many different types of treatment can alleviate symptoms and/or modify the disease process.</p>
<p>The goal of treatment is two-fold: alleviating the current symptoms, and preventing the future destruction of the joints with the resulting handicap if the disease is left unchecked. These two goals may not always coincide: while pain relievers may achieve the first goal, they do not have any impact on the long-term consequences. For these reasons, most authorities believe that most RA should be treated by at least one specific anti-rheumatic medication, also named DMARD (see below), to which other medications and non-medical interventions can be added as needed.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a href="/wiki/Cortisone" title="Cortisone">Cortisone</a> therapy has offered relief in the past, but its long-term effects have been deemed undesirable.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup>. However, cortisone injections can be valuable adjuncts to a long-term treatment plan, and using low dosages of daily cortisone (e.g., prednisone or prednisolone, 5-7.5 mg daily) can also have an important benefit if added to a proper specific anti-rheumatic treatment.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a href="/wiki/Pharmacology" title="Pharmacology">Pharmacological</a> treatment of RA can be divided into disease-modifying antirheumatic drugs (DMARDs), anti-inflammatory agents and <a href="/wiki/Analgesic" title="Analgesic">analgesics</a>.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup> Treatment also includes rest and physical activity.</p>
<p><a name="Disease_modifying_anti-rheumatic_drugs_.28DMARDs.29" id="Disease_modifying_anti-rheumatic_drugs_.28DMARDs.29"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=15" title="Edit section: Disease modifying anti-rheumatic drugs (DMARDs)">edit</a>]</span> <span class="mw-headline">Disease modifying anti-rheumatic drugs (DMARDs)</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Disease-modifying_antirheumatic_drug" title="Disease-modifying antirheumatic drug">Disease-modifying antirheumatic drug</a></div>
<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Question_book-new.svg" class="image" title="Question book-new.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This article <b>needs additional <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">citations</a> for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a>.</b> Please help <a href="http://en.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" rel="nofollow">improve this article</a> by adding <a href="/wiki/Wikipedia:Reliable_sources" title="Wikipedia:Reliable sources">reliable references</a> (ideally, using <i><a href="/wiki/Wikipedia:Footnotes" title="Wikipedia:Footnotes">inline citations</a></i>). Unsourced material may be <a href="/wiki/Template:Fact" title="Template:Fact">challenged</a> and <a href="/wiki/Wikipedia:BURDEN" title="Wikipedia:BURDEN" class="mw-redirect">removed</a>. <small><i>(October 2008)</i></small></td>
</tr>
</table>
<p>The term Disease modifying anti-rheumatic drug (DMARD) originally meant a drug that affects biological measures such as ESR and haemoglobin and autoantibody levels, but is now usually used to mean a drug that reduces the rate of damage to bone and cartilage. DMARDs have been found both to produce durable symptomatic remissions and to delay or halt progression. This is important as such damage is usually irreversible. Anti-inflammatories and analgesics improve pain and stiffness but do not prevent joint damage or slow the disease progression.</p>
<p>There is an increasing recognition among rheumatologists that permanent damage to the joints occurs at a very early stage in the disease. In the past it was common to start with just an anti-inflammatory drug, and assess progression clinically and using X-rays. If there was evidence that joint damage was starting to occur then a more potent DMARD would be prescribed. Ultrasound and MRI are more sensitive methods of imaging the joints and have demonstrated that joint damage occurs much earlier and in more sufferers than was previously thought. People with normal X-rays will often have erosions detectable by ultrasound that X ray could not demonstrate. The aim now is to treat before damage occurs.</p>
<p>There may be other reasons why starting DMARDs early is beneficial as well as prevention of structural joint damage. From the earliest stages of the disease, the joints are infiltrated by cells of the immune system that signal to one another in ways that may involve a variety of positive feedback loops (it has long been observed that a single corticosteroid injection may abort synovitis in a particular joint for long periods). Interrupting this process as early as possible with an effective DMARD (such as methotrexate) appears to improve the outcome from the RA for years afterwards. Delaying therapy for as little as a few months after the onset of symptoms can result in worse outcomes in the long term. There is therefore considerable interest in establishing the most effective therapy with early arthritis, when they are most responsive to therapy and have the most to gain.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup></p>
<p><a name="Traditional_small_molecular_mass_drugs" id="Traditional_small_molecular_mass_drugs"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=16" title="Edit section: Traditional small molecular mass drugs">edit</a>]</span> <span class="mw-headline">Traditional small molecular mass drugs</span></h4>
<p>Chemically synthesised DMARDs:</p>
<ul>
<li><a href="/wiki/Azathioprine" title="Azathioprine">azathioprine</a></li>
<li><a href="/wiki/Ciclosporin" title="Ciclosporin">ciclosporin</a> (cyclosporine A)</li>
<li><a href="/wiki/D-penicillamine" title="D-penicillamine" class="mw-redirect">D-penicillamine</a></li>
<li><a href="/wiki/Gold_salts" title="Gold salts">gold salts</a></li>
<li><a href="/wiki/Hydroxychloroquine" title="Hydroxychloroquine">hydroxychloroquine</a></li>
<li><a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a></li>
<li><a href="/wiki/Methotrexate" title="Methotrexate">methotrexate (MTX)</a></li>
<li><a href="/wiki/Minocycline" title="Minocycline">minocycline</a></li>
<li><a href="/wiki/Sulfasalazine" title="Sulfasalazine">sulfasalazine</a> (SSZ)</li>
</ul>
<p>Cytotoxic drugs:</p>
<ul>
<li><a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
</ul>
<p>The most important and most common adverse events relate to <a href="/wiki/Liver" title="Liver">liver</a> and <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> toxicity (MTX, SSZ, leflunomide, azathioprine, gold compounds, D-penicillamine), renal toxicity (cyclosporine A, parenteral gold salts, D-penicillamine), pneumonitis (MTX), allergic skin reactions (gold compounds, SSZ), autoimmunity (D-penicillamine, SSZ, minocycline) and infections (azathioprine, cyclosporine A). Hydroxychloroquine may cause ocular toxicity, although this is rare, and because hydroxychloroquine does not affect the bone marrow or liver it is often considered to be the DMARD with the least toxicity. Unfortunately hydroxychloroquine is not very potent, and is usually insufficient to control symptoms on its own.</p>
<p>Many rheumatologists consider methotrexate to be the most important and useful DMARD, largely because of lower drop-out rates for reasons of toxicity. Nevertheless, methotrexate is often considered as a very 'toxic' drug. This reputation is not entirely justified, and at times can result in people being denied the most effective treatment for their arthritis. Although methotrexate does have the potential to suppress bone marrow or cause hepatitis, these effects can be monitored using regular blood tests, and the drug withdrawn at an early stage if the tests are abnormal before any serious harm is done (typically the blood tests return to normal after stopping the drug). In clinical trials, where one of a range of different DMARDs were used, people who were prescribed methotrexate stayed on their medication the longest (the others stopped because of either side-effects or failure of the drug to control the arthritis). Methotrexate is often preferred by rheumatologists because if it does not control arthritis on its own then it works well in combination with many other drugs, especially the biological agents. Other DMARDs may not be as effective or as safe in combination with biological agents.</p>
<p><a name="Biological_agents" id="Biological_agents"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=17" title="Edit section: Biological agents">edit</a>]</span> <span class="mw-headline">Biological agents</span></h4>
<p>Biological agents (biologics) are produced through genetic engineering, and include:</p>
<ul>
<li><a href="/wiki/Tumor_necrosis_factor_alpha" title="Tumor necrosis factor alpha" class="mw-redirect">tumor necrosis factor alpha</a> (TNFα) blockers - <a href="/wiki/Etanercept" title="Etanercept">etanercept</a> (Enbrel), <a href="/wiki/Infliximab" title="Infliximab">infliximab</a> (Remicade), <a href="/wiki/Adalimumab" title="Adalimumab">adalimumab</a> (Humira)</li>
<li><a href="/wiki/Interleukin_1" title="Interleukin 1">Interleukin 1</a> (IL-1) blockers - <a href="/wiki/Anakinra" title="Anakinra">anakinra</a> (Kineret)</li>
<li><a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody" class="mw-redirect">monoclonal antibodies</a> against <a href="/wiki/B_cell" title="B cell">B cells</a> - <a href="/wiki/Rituximab" title="Rituximab">rituximab</a> (Rituxan)<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup></li>
<li><a href="/wiki/T_cell" title="T cell">T cell</a> costimulation blocker - <a href="/wiki/Abatacept" title="Abatacept">abatacept</a> (Orencia)</li>
<li><a href="/wiki/Interleukin_6" title="Interleukin 6">Interleukin 6</a> (IL-6) blockers - <a href="/wiki/Tocilizumab" title="Tocilizumab">tocilizumab</a> (an anti-IL-6 receptor antibody) (RoActemra, Actemra)</li>
</ul>
<p><a name="Anti-inflammatory_agents_and_analgesics" id="Anti-inflammatory_agents_and_analgesics"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=18" title="Edit section: Anti-inflammatory agents and analgesics">edit</a>]</span> <span class="mw-headline">Anti-inflammatory agents and analgesics</span></h3>
<p>Anti-inflammatory agents include:</p>
<ul>
<li><a href="/wiki/Glucocorticoids" title="Glucocorticoids" class="mw-redirect">glucocorticoids</a></li>
<li><a href="/wiki/Non-steroidal_anti-inflammatory_drug" title="Non-steroidal anti-inflammatory drug">Non-steroidal anti-inflammatory drug</a> (NSAIDs, most also act as analgesics)</li>
</ul>
<p>Analgesics include:</p>
<ul>
<li>paracetamol (acetaminophen in US and Canada!)</li>
<li><a href="/wiki/Opiates" title="Opiates" class="mw-redirect">opiates</a></li>
<li><a href="/wiki/Diproqualone" title="Diproqualone">diproqualone</a></li>
<li><a href="/wiki/Lidocaine" title="Lidocaine">lidocaine</a> topical</li>
</ul>
<p>The <a href="/wiki/Prosorba_column" title="Prosorba column">Prosorba column</a> blood filtering device was approved by the FDA for treatment of RA in 1999 <sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> However, the results have been very modest.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>Historic treatments for RA have also included: <a href="/wiki/RICE_(medicine)" title="RICE (medicine)">rest, ice , compression and elevation</a>, <a href="/wiki/Acupuncture" title="Acupuncture">acupuncture</a>, <a href="/wiki/Apple" title="Apple">apple</a> diet, <a href="/wiki/Nutmeg" title="Nutmeg">nutmeg</a>, some light exercise every now and then, <a href="/wiki/Nettle" title="Nettle">nettles</a>, <a href="/wiki/Bee" title="Bee">bee</a> venom, <a href="/wiki/Copper" title="Copper">copper</a> bracelets, <a href="/wiki/Rhubarb_diet" title="Rhubarb diet">rhubarb diet</a>, rest, extractions of teeth, <a href="/wiki/Fasting" title="Fasting">fasting</a>, <a href="/wiki/Honey" title="Honey">honey</a>, <a href="/wiki/Vitamin" title="Vitamin">vitamins</a>, <a href="/wiki/Insulin" title="Insulin">insulin</a>, <a href="/wiki/Magnet" title="Magnet">magnets</a>, and <a href="/wiki/Electroconvulsive_therapy" title="Electroconvulsive therapy">electroconvulsive therapy</a> (ECT).<sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup>. Most of these have either had no effect at all, or their effects have been modest and transient, while not being generalizable.</p>
<p><a name="Other_therapies" id="Other_therapies"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=19" title="Edit section: Other therapies">edit</a>]</span> <span class="mw-headline">Other therapies</span></h3>
<p>Other therapies are <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a>, occupational therapy, <a href="/wiki/Podiatry" title="Podiatry">podiatry</a>, <a href="/wiki/Physiotherapy" title="Physiotherapy" class="mw-redirect">physiotherapy</a>, <a href="/w/index.php?title=Immunoadsorbtion_therapy&amp;action=edit&amp;redlink=1" class="new" title="Immunoadsorbtion therapy (page does not exist)">immunoadsorbtion therapy</a>, <a href="/wiki/Joint_injection" title="Joint injection">joint injections</a>, and special tools to improve hard movements (e.g. special tin-openers). Regular exercise is important for maintaining joint mobility and making the joint muscles stronger. Swimming is especially good, as it allows for exercise with a minimum of stress on the joints. Heat and cold applications are modalities that can ease symptoms before and after exercise. Pain in the joints is sometimes alleviated by oral <a href="/wiki/Ibuprofen" title="Ibuprofen">ibuprofen</a> or other anti-inflammatory. Other areas of the body, such as the eyes and lining of the heart, are treated individually. Fish oil may have anti-inflammatory effects.</p>
<p><a href="/wiki/Radon_therapy" title="Radon therapy">Radon therapy</a>, popular in Germany and Eastern Europe, can induce beneficial long-term effects for rheumatoid arthritis.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup></p>
<p>A survey in the United Kingdom between 1998 and 2002 found arthritis to be reported among the five most common reasons for the <a href="/wiki/Medical_marijuana" title="Medical marijuana" class="mw-redirect">medicinal use of cannabis</a>.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup></p>
<p>The resulting effectiveness of treating RA with acupuncture is inconclusive, and "more rigorous research seems to be warranted" according to one study.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup> Severely affected joints may require <a href="/wiki/Joint_replacement" title="Joint replacement">joint replacement</a> surgery, such as knee replacement.</p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=20" title="Edit section: Prognosis">edit</a>]</span> <span class="mw-headline">Prognosis</span></h2>
<p>The course of the disease varies greatly. Some people have mild short-term symptoms, but in most the disease is progressive for life. Around 20%-30% will have subcutaneous nodules (known as rheumatoid nodules); this is associated with a poor prognosis.</p>
<p><a name="Disability" id="Disability"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=21" title="Edit section: Disability">edit</a>]</span> <span class="mw-headline">Disability</span></h3>
<ul>
<li>Daily living activities are impaired in most individuals.</li>
<li>After 5 years of disease, approximately 33% of sufferers will not be working.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></li>
<li>After 10 years, approximately half will have substantial functional disability.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></li>
</ul>
<p><a name="Prognostic_factors" id="Prognostic_factors"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=22" title="Edit section: Prognostic factors">edit</a>]</span> <span class="mw-headline">Prognostic factors</span></h3>
<p>Poor prognostic factors include persistent synovitis, early erosive disease, extra-articular findings (including subcutaneous rheumatoid nodules), positive serum RF findings, positive serum anti-CCP autoantibodies, carriership of HLA-DR4 "Shared Epitope" alleles, family history of RA, poor functional status, socioeconomic factors, elevated acute phase response (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]), and increased clinical severity.</p>
<p><a name="Mortality" id="Mortality"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=23" title="Edit section: Mortality">edit</a>]</span> <span class="mw-headline">Mortality</span></h3>
<p>Estimates of the life-shortening effect of RA vary; most sources cite a lifespan reduction of 5 to 10 years. According to the <a href="/wiki/UK" title="UK" class="mw-redirect">UK</a>'s National Rheumatoid Arthritis Society, "Young age at onset, long disease duration, the concurrent presence of other health problems (called co-morbidity), and characteristics of severe RA – such as poor functional ability or overall health status, a lot of joint damage on x-rays, the need for hospitalisation or involvement of organs other than the joints – have been shown to associate with higher mortality".<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup> Positive responses to treatment may indicate a better prognosis. A 2005 study by the <a href="/wiki/Mayo_Clinic" title="Mayo Clinic">Mayo Clinic</a> noted that RA sufferers suffer a doubled risk of heart disease,<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup> independent of other risk factors such as <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a>, alcohol abuse, and elevated <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a>, blood pressure and <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a>. The mechanism by which RA causes this increased risk remains unknown; the presence of chronic inflammation has been proposed as a contributing factor.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=24" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<p>The <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> of RA is in the region of 3 cases per 10,000 population per annum. Onset is uncommon under the age of 15 and from then on the incidence rises with age until the age of 80. The <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> rate is 1%, with women affected three to five times as often as men. It is 4 times more common in smokers than non-smokers. Some <a href="/wiki/Indigenous_peoples_of_the_Americas" title="Indigenous peoples of the Americas">Native American</a> groups have higher prevalence rates (5-6%) and people from the <a href="/wiki/Caribbean" title="Caribbean">Caribbean</a> region have lower prevalence rates. First-degree relatives prevalence rate is 2-3% and disease <a href="/wiki/Genetic_concordance" title="Genetic concordance" class="mw-redirect">genetic concordance</a> in <a href="/wiki/Twin#Identical_twins" title="Twin">monozygotic twins</a> is approximately 15-20%.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>It is strongly associated with the inherited tissue type <a href="/wiki/Major_histocompatibility_complex" title="Major histocompatibility complex">Major histocompatibility complex</a> (MHC) antigen <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">HLA</a>-DR4 (most specifically DR0401 and 0404) — hence family history is an important risk factor.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>Rheumatoid arthritis affects women three times more often than men, and it can first develop at any age. The risk of first developing the disease (the disease <a href="/wiki/Incidence" title="Incidence">incidence</a>) appears to be greatest for women between 40 and 50 years of age, and for men somewhat later.<sup id="cite_ref-pmid17045630_33-0" class="reference"><a href="#cite_note-pmid17045630-33" title=""><span>[</span>34<span>]</span></a></sup> RA is a chronic disease, and although rarely, a spontaneous remission may occur, the natural course is almost invariably one of persistent symptoms, waxing and waning in intensity, and a progressive deterioration of joint structures leading to deformations and disability.</p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=25" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The first known traces of arthritis date back at least as far as <a href="/wiki/4500_BC" title="4500 BC" class="mw-redirect">4500 BC</a>. A text dated <a href="/wiki/123_AD" title="123 AD" class="mw-redirect">123 AD</a> first describes <a href="/wiki/Symptom" title="Symptom">symptoms</a> very similar to rheumatoid arthritis. It was noted in skeletal remains of Native Americans found in <a href="/wiki/Tennessee" title="Tennessee">Tennessee</a>.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> In the Old World the disease is vanishingly rare before the 1600s.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup> and on this basis investigators believe it spread across the Atlantic during the <a href="/wiki/Age_of_Exploration" title="Age of Exploration" class="mw-redirect">Age of Exploration</a>. In 1859 the disease acquired its current name.</p>
<p>An anomaly has been noticed from investigation of Precolumbian bones. The bones from the Tennessee site show no signs of tuberculosis even though it was prevalent at the time throughout the Americas.<sup id="cite_ref-pmid14528501_36-0" class="reference"><a href="#cite_note-pmid14528501-36" title=""><span>[</span>37<span>]</span></a></sup> Jim Mobley, at Pfizer, has discovered a historical pattern of epidemics of tuberculosis followed by a surge in the number of rheumatoid arthritis cases a few generations later.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup> Mobley attributes the spikes in arthritis to selective pressure caused by tuberculosis. A hypervigilant immune system is protective against tuberculosis at the cost of an increased risk of autoimmune disease.</p>
<p>The art of <a href="/wiki/Peter_Paul_Rubens" title="Peter Paul Rubens">Peter Paul Rubens</a> may possibly depict the effects of rheumatoid arthritis. In his later paintings, his rendered hands show, in the opinion of some physicians, increasing deformity consistent with the symptoms of the disease.<sup id="cite_ref-pmid7005475_38-0" class="reference"><a href="#cite_note-pmid7005475-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup> Rheumatoid arthritis appears to some to have been depicted in 16th century paintings.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup> However, it is generally recognised in art historical circles that the painting of hands in the sixteenth and seventeenth century followed certain stylised conventions, most clearly seen in the Mannerist movement. It was conventional, for instance to show the upheld right hand of Christ in what now appears a deformed posture. These conventions are easily misinterpreted as portrayals of disease. They are much too widespread for this to be plausible.</p>
<p>The first recognized description of rheumatoid arthritis was in 1800 by the French physician Dr Augustin Jacob Landré-Beauvais (1772-1840) who was based in the famed <a href="/wiki/Piti%C3%A9-Salp%C3%AAtri%C3%A8re_Hospital" title="Pitié-Salpêtrière Hospital">Salpêtrière Hospital</a> in Paris.<sup id="cite_ref-Landre1800_1-1" class="reference"><a href="#cite_note-Landre1800-1" title=""><span>[</span>2<span>]</span></a></sup> The name "rheumatoid arthritis" itself was coined in 1859 by British rheumatologist Dr <a href="/wiki/Alfred_Baring_Garrod" title="Alfred Baring Garrod">Alfred Baring Garrod</a>.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup></p>
<p><a name="Notable_cases" id="Notable_cases"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=26" title="Edit section: Notable cases">edit</a>]</span> <span class="mw-headline">Notable cases</span></h3>
<ul>
<li><a href="/wiki/Dorothy_Hodgkin" title="Dorothy Hodgkin">Dorothy Hodgkin</a>, Nobel prize winning scientist, developed severe deforming rheumatoid arthritis at age 28. In spite of this she continued her career and developed <a href="/wiki/X-ray_crystallography" title="X-ray crystallography">X-ray crystallography</a>, underpinning a lot of information about rheumatoid arthritis, discovered the structure of <a href="/wiki/Insulin" title="Insulin">insulin</a> and enabled discovery of the <a href="/wiki/Genetic_code" title="Genetic code">genetic code</a>.</li>
<li><a href="/wiki/Auguste_Renoir" title="Auguste Renoir" class="mw-redirect">Auguste Renoir</a>, impressionist painter, whose later 'softer' style might have reflected in some way his severe disability.</li>
<li><a href="/wiki/Christiaan_Barnard" title="Christiaan Barnard">Christiaan Barnard</a>, the first surgeon to perform a human-to-human heart transplant had to retire owing to the condition. He also wrote a book on living with arthritis.</li>
<li><a href="/wiki/James_Coburn" title="James Coburn">James Coburn</a> claimed to have healed the condition using pills containing a sulfur-containing compound on his return to acting.</li>
<li><a href="/wiki/Erik_Lindbergh" title="Erik Lindbergh">Erik Lindbergh</a>, aviator and member of the <a href="/wiki/X-Prize" title="X-Prize" class="mw-redirect">X-Prize</a> administration. Erik has been a spokesman for the arthritis drug <a href="/wiki/Enbrel" title="Enbrel" class="mw-redirect">Enbrel</a>, as a result of his success with the treatment.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42" title=""><span>[</span>43<span>]</span></a></sup></li>
<li><a href="/wiki/Kathleen_Turner" title="Kathleen Turner">Kathleen Turner</a> and <a href="/wiki/Aida_Turturro" title="Aida Turturro">Aida Turturro</a> have worked to raise public awareness of the condition<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup></li>
<li><a href="/wiki/Billy_Bowden" title="Billy Bowden">Billy Bowden</a>, international cricket umpire who had to retire from active playing due to RA</li>
<li><a href="/wiki/Melvin_Franklin" title="Melvin Franklin">Melvin Franklin</a>, bass singer of the Temptations. He treated RA with cortisone shots so he could perform.</li>
<li><a href="/wiki/Christopher_Lee" title="Christopher Lee">Christopher Lee</a>, British actor, who has to use special, ergonomically designed props when he works on set<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></li>
<li><a href="/wiki/Jamie_Farr" title="Jamie Farr">Jamie Farr</a>, American actor, famous for his role as <a href="/wiki/Maxwell_Klinger" title="Maxwell Klinger">Max Klinger</a> on the 1970's <a href="/wiki/Television" title="Television">television</a> series <a href="/wiki/M*A*S*H" title="M*A*S*H">M*A*S*H</a>.</li>
</ul>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=27" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">Juvenile idiopathic arthritis</a></li>
<li><a href="/wiki/Synovitis" title="Synovitis">Synovitis</a></li>
<li><a href="/wiki/Biologics" title="Biologics">Biologics</a></li>
<li><a href="/wiki/Arthritis_Care" title="Arthritis Care">Arthritis Care</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=28" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-Majithia2007-0">^ <a href="#cite_ref-Majithia2007_0-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Majithia2007_0-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Majithia2007_0-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMajithia_V.2C_Geraci_SA2007">Majithia V, Geraci SA (2007). "Rheumatoid arthritis: diagnosis and management". <i>Am. J. Med.</i> <b>120</b> (11): 936–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.amjmed.2007.04.005" class="external text" title="http://dx.doi.org/10.1016%2Fj.amjmed.2007.04.005" rel="nofollow">10.1016/j.amjmed.2007.04.005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17976416" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17976416">PMID 17976416</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rheumatoid+arthritis%3A+diagnosis+and+management&amp;rft.jtitle=Am.+J.+Med.&amp;rft.aulast=Majithia+V%2C+Geraci+SA&amp;rft.au=Majithia+V%2C+Geraci+SA&amp;rft.date=2007&amp;rft.volume=120&amp;rft.issue=11&amp;rft.pages=936%E2%80%939&amp;rft_id=info:doi/10.1016%2Fj.amjmed.2007.04.005&amp;rft_id=info:pmid/17976416&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Landre1800-1">^ <a href="#cite_ref-Landre1800_1-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Landre1800_1-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="book" id="CITEREFLandr.C3.A9-Beauvais_AJ1800">Landré-Beauvais AJ (1800). <i>La goutte asthénique primitive (doctoral thesis)</i>. Paris.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=La+goutte+asth%C3%A9nique+primitive+%28doctoral+thesis%29&amp;rft.aulast=Landr%C3%A9-Beauvais+AJ&amp;rft.au=Landr%C3%A9-Beauvais+AJ&amp;rft.date=1800&amp;rft.place=Paris&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span> reproduced in <cite style="font-style:normal" class="" id="CITEREFLandr.C3.A9-Beauvais_AJ2001">Landré-Beauvais AJ (March 2001). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S1297319X00002475" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S1297319X00002475" rel="nofollow">The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800</a>". <i>Joint Bone Spine</i> <b>68</b> (2): 130–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1297-319X%2800%2900247-5" class="external text" title="http://dx.doi.org/10.1016%2FS1297-319X%2800%2900247-5" rel="nofollow">10.1016/S1297-319X(00)00247-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11324929" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11324929">PMID 11324929</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S1297319X00002475" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S1297319X00002475" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S1297319X00002475</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+first+description+of+rheumatoid+arthritis.+Unabridged+text+of+the+doctoral+dissertation+presented+in+1800&amp;rft.jtitle=Joint+Bone+Spine&amp;rft.aulast=Landr%C3%A9-Beauvais+AJ&amp;rft.au=Landr%C3%A9-Beauvais+AJ&amp;rft.date=March+2001&amp;rft.volume=68&amp;rft.issue=2&amp;rft.pages=130%E2%80%9343&amp;rft_id=info:doi/10.1016%2FS1297-319X%2800%2900247-5&amp;rft_id=info:pmid/11324929&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1297319X00002475&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12860726-2"><b><a href="#cite_ref-pmid12860726_2-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTuresson_C.2C_O.27Fallon_WM.2C_Crowson_CS.2C_Gabriel_SE.2C_Matteson_EL2003">Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003). "Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years". <i>Ann. Rheum. Dis.</i> <b>62</b> (8): 722–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fard.62.8.722" class="external text" title="http://dx.doi.org/10.1136%2Fard.62.8.722" rel="nofollow">10.1136/ard.62.8.722</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12860726" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12860726">PMID 12860726</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Extra-articular+disease+manifestations+in+rheumatoid+arthritis%3A+incidence+trends+and+risk+factors+over+46+years&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.aulast=Turesson+C%2C+O%27Fallon+WM%2C+Crowson+CS%2C+Gabriel+SE%2C+Matteson+EL&amp;rft.au=Turesson+C%2C+O%27Fallon+WM%2C+Crowson+CS%2C+Gabriel+SE%2C+Matteson+EL&amp;rft.date=2003&amp;rft.volume=62&amp;rft.issue=8&amp;rft.pages=722%E2%80%937&amp;rft_id=info:doi/10.1136%2Fard.62.8.722&amp;rft_id=info:pmid/12860726&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> <a href="http://medicalpresentations.lifehugger.com/doc/approach-early-arthritis" class="external text" title="http://medicalpresentations.lifehugger.com/doc/approach-early-arthritis" rel="nofollow">Jijith Krishnan,Document on Rhuematoid arthritis</a></li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFde_Groot_K2007">de Groot K (August 2007). "[Renal manifestations in rheumatic diseases]". <i>Internist (Berl)</i> <b>48</b> (8): 779–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00108-007-1887-9" class="external text" title="http://dx.doi.org/10.1007%2Fs00108-007-1887-9" rel="nofollow">10.1007/s00108-007-1887-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17571244" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17571244">PMID 17571244</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BRenal+manifestations+in+rheumatic+diseases%5D&amp;rft.jtitle=Internist+%28Berl%29&amp;rft.aulast=de+Groot+K&amp;rft.au=de+Groot+K&amp;rft.date=August+2007&amp;rft.volume=48&amp;rft.issue=8&amp;rft.pages=779%E2%80%9385&amp;rft_id=info:doi/10.1007%2Fs00108-007-1887-9&amp;rft_id=info:pmid/17571244&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWolfe_F.2C_Mitchell_DM.2C_Sibley_JT.2C_.27.27et_al.27.271994">Wolfe F, Mitchell DM, Sibley JT, <i>et al</i> (April 1994). "The mortality of rheumatoid arthritis". <i>Arthritis Rheum.</i> <b>37</b> (4): 481–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fart.1780370408" class="external text" title="http://dx.doi.org/10.1002%2Fart.1780370408" rel="nofollow">10.1002/art.1780370408</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8147925" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8147925">PMID 8147925</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+mortality+of+rheumatoid+arthritis&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.aulast=Wolfe+F%2C+Mitchell+DM%2C+Sibley+JT%2C+%27%27et+al%27%27&amp;rft.au=Wolfe+F%2C+Mitchell+DM%2C+Sibley+JT%2C+%27%27et+al%27%27&amp;rft.date=April+1994&amp;rft.volume=37&amp;rft.issue=4&amp;rft.pages=481%E2%80%9394&amp;rft_id=info:doi/10.1002%2Fart.1780370408&amp;rft_id=info:pmid/8147925&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWestwood_OM.2C_Nelson_PN.2C_Hay_FC2006">Westwood OM, Nelson PN, Hay FC (April 2006). "<a href="http://rheumatology.oxfordjournals.org/cgi/content/full/45/4/379" class="external text" title="http://rheumatology.oxfordjournals.org/cgi/content/full/45/4/379" rel="nofollow">Rheumatoid factors: what's new?</a>". <i>Rheumatology (Oxford)</i> <b>45</b> (4): 379–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Frheumatology%2Fkei228" class="external text" title="http://dx.doi.org/10.1093%2Frheumatology%2Fkei228" rel="nofollow">10.1093/rheumatology/kei228</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16418203" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16418203">PMID 16418203</a><span class="printonly">. <a href="http://rheumatology.oxfordjournals.org/cgi/content/full/45/4/379" class="external free" title="http://rheumatology.oxfordjournals.org/cgi/content/full/45/4/379" rel="nofollow">http://rheumatology.oxfordjournals.org/cgi/content/full/45/4/379</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rheumatoid+factors%3A+what%27s+new%3F&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.aulast=Westwood+OM%2C+Nelson+PN%2C+Hay+FC&amp;rft.au=Westwood+OM%2C+Nelson+PN%2C+Hay+FC&amp;rft.date=April+2006&amp;rft.volume=45&amp;rft.issue=4&amp;rft.pages=379%E2%80%9385&amp;rft_id=info:doi/10.1093%2Frheumatology%2Fkei228&amp;rft_id=info:pmid/16418203&amp;rft_id=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Ffull%2F45%2F4%2F379&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Nishimura-7">^ <a href="#cite_ref-Nishimura_7-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nishimura_7-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFNishimura_K.2C_Sugiyama_D.2C_Kogata_Y.2C_.27.27et_al.27.272007">Nishimura K, Sugiyama D, Kogata Y, <i>et al</i> (June 2007). "<a href="http://www.annals.org/cgi/reprint/146/11/797" class="external text" title="http://www.annals.org/cgi/reprint/146/11/797" rel="nofollow">Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis</a>" (PDF). <i>Ann. Intern. Med.</i> <b>146</b> (11): 797–808. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17548411" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17548411">PMID 17548411</a><span class="printonly">. <a href="http://www.annals.org/cgi/reprint/146/11/797" class="external free" title="http://www.annals.org/cgi/reprint/146/11/797" rel="nofollow">http://www.annals.org/cgi/reprint/146/11/797</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Meta-analysis%3A+diagnostic+accuracy+of+anti-cyclic+citrullinated+peptide+antibody+and+rheumatoid+factor+for+rheumatoid+arthritis&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.aulast=Nishimura+K%2C+Sugiyama+D%2C+Kogata+Y%2C+%27%27et+al%27%27&amp;rft.au=Nishimura+K%2C+Sugiyama+D%2C+Kogata+Y%2C+%27%27et+al%27%27&amp;rft.date=June+2007&amp;rft.volume=146&amp;rft.issue=11&amp;rft.pages=797%E2%80%93808&amp;rft_id=info:pmid/17548411&amp;rft_id=http%3A%2F%2Fwww.annals.org%2Fcgi%2Freprint%2F146%2F11%2F797&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFArnett_F.2C_Edworthy_S.2C_Bloch_D.2C_McShane_D.2C_Fries_J.2C_Cooper_N.2C_Healey_L.2C_Kaplan_S.2C_Liang_M.2C_Luthra_H1988">Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N, Healey L, Kaplan S, Liang M, Luthra H (1988). "<a href="http://www.rheumatology.org/publications/classification/ra/ra.asp?aud=mem" class="external text" title="http://www.rheumatology.org/publications/classification/ra/ra.asp?aud=mem" rel="nofollow">The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.</a>". <i>Arthritis Rheum</i> <b>31</b> (3): 315–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fart.1780310302" class="external text" title="http://dx.doi.org/10.1002%2Fart.1780310302" rel="nofollow">10.1002/art.1780310302</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3358796" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3358796">PMID 3358796</a><span class="printonly">. <a href="http://www.rheumatology.org/publications/classification/ra/ra.asp?aud=mem" class="external free" title="http://www.rheumatology.org/publications/classification/ra/ra.asp?aud=mem" rel="nofollow">http://www.rheumatology.org/publications/classification/ra/ra.asp?aud=mem</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+American+Rheumatism+Association+1987+revised+criteria+for+the+classification+of+rheumatoid+arthritis.&amp;rft.jtitle=Arthritis+Rheum&amp;rft.aulast=Arnett+F%2C+Edworthy+S%2C+Bloch+D%2C+McShane+D%2C+Fries+J%2C+Cooper+N%2C+Healey+L%2C+Kaplan+S%2C+Liang+M%2C+Luthra+H&amp;rft.au=Arnett+F%2C+Edworthy+S%2C+Bloch+D%2C+McShane+D%2C+Fries+J%2C+Cooper+N%2C+Healey+L%2C+Kaplan+S%2C+Liang+M%2C+Luthra+H&amp;rft.date=1988&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=315%E2%80%9324&amp;rft_id=info:doi/10.1002%2Fart.1780310302&amp;rft_id=info:pmid/3358796&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2Fpublications%2Fclassification%2Fra%2Fra.asp%3Faud%3Dmem&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Merckmanual-9">^ <a href="#cite_ref-Merckmanual_9-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Merckmanual_9-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="book" id="CITEREFBerkow_R1992">Berkow R, ed (1992). <i>The Merck Manual</i> (16th ed.). Merck Publishing Group. pp.&#160;1307–08. <a href="/wiki/Special:BookSources/0911910166" class="internal">ISBN 0-91191-016-6</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Merck+Manual&amp;rft.date=1992&amp;rft.pages=pp.%26nbsp%3B1307%E2%80%9308&amp;rft.edition=16th&amp;rft.pub=Merck+Publishing+Group&amp;rft.isbn=0-91191-016-6&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-urlSUNY_Stony_Brook_Pathology_Department_HBP310_Immunology-10"><b><a href="#cite_ref-urlSUNY_Stony_Brook_Pathology_Department_HBP310_Immunology_10-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.path.sunysb.edu/coursemat/hbp310immun.htm" class="external text" title="http://www.path.sunysb.edu/coursemat/hbp310immun.htm" rel="nofollow">"SUNY Stony Brook Pathology Department HBP310 Immunology"</a><span class="printonly">. <a href="http://www.path.sunysb.edu/coursemat/hbp310immun.htm" class="external free" title="http://www.path.sunysb.edu/coursemat/hbp310immun.htm" rel="nofollow">http://www.path.sunysb.edu/coursemat/hbp310immun.htm</a></span><span class="reference-accessdate">. Retrieved on 2008-09-20</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=SUNY+Stony+Brook+Pathology+Department+HBP310+Immunology&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.path.sunysb.edu%2Fcoursemat%2Fhbp310immun.htm&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-urlHypersensitivity_reactions-11"><b><a href="#cite_ref-urlHypersensitivity_reactions_11-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://pathmicro.med.sc.edu/ghaffar/hyper00.htm" class="external text" title="http://pathmicro.med.sc.edu/ghaffar/hyper00.htm" rel="nofollow">"Hypersensitivity reactions"</a><span class="printonly">. <a href="http://pathmicro.med.sc.edu/ghaffar/hyper00.htm" class="external free" title="http://pathmicro.med.sc.edu/ghaffar/hyper00.htm" rel="nofollow">http://pathmicro.med.sc.edu/ghaffar/hyper00.htm</a></span><span class="reference-accessdate">. Retrieved on 2008-09-20</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Hypersensitivity+reactions&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fpathmicro.med.sc.edu%2Fghaffar%2Fhyper00.htm&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-urlLecture_14:_Hypersensitivity-12"><b><a href="#cite_ref-urlLecture_14:_Hypersensitivity_12-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html" class="external text" title="http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html" rel="nofollow">"Lecture 14: Hypersensitivity"</a><span class="printonly">. <a href="http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html" class="external free" title="http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html" rel="nofollow">http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html</a></span><span class="reference-accessdate">. Retrieved on 2008-09-20</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Lecture+14%3A+Hypersensitivity&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww-immuno.path.cam.ac.uk%2F%7Eimmuno%2Fpart1%2Flec13%2Flec13_97.html&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> Edwards JC, Cambridge G, Abrahams VM. Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology. 1999;97:188-96.</li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlvarez-Lafuente_R.2C_Fern.C3.A1ndez-Guti.C3.A9rrez_B.2C_de_Miguel_S.2C_.27.27et_al.27.272005">Alvarez-Lafuente R, Fernández-Gutiérrez B, de Miguel S, <i>et al</i> (September 2005). "<a href="http://ard.bmj.com/cgi/content/abstract/64/9/1357" class="external text" title="http://ard.bmj.com/cgi/content/abstract/64/9/1357" rel="nofollow">Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction</a>". <i>Ann. Rheum. Dis.</i> <b>64</b> (9): 1357–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fard.2004.033514" class="external text" title="http://dx.doi.org/10.1136%2Fard.2004.033514" rel="nofollow">10.1136/ard.2004.033514</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16100341" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16100341">PMID 16100341</a><span class="printonly">. <a href="http://ard.bmj.com/cgi/content/abstract/64/9/1357" class="external free" title="http://ard.bmj.com/cgi/content/abstract/64/9/1357" rel="nofollow">http://ard.bmj.com/cgi/content/abstract/64/9/1357</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Potential+relationship+between+herpes+viruses+and+rheumatoid+arthritis%3A+analysis+with+quantitative+real+time+polymerase+chain+reaction&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.aulast=Alvarez-Lafuente+R%2C+Fern%C3%A1ndez-Guti%C3%A9rrez+B%2C+de+Miguel+S%2C+%27%27et+al%27%27&amp;rft.au=Alvarez-Lafuente+R%2C+Fern%C3%A1ndez-Guti%C3%A9rrez+B%2C+de+Miguel+S%2C+%27%27et+al%27%27&amp;rft.date=September+2005&amp;rft.volume=64&amp;rft.issue=9&amp;rft.pages=1357%E2%80%939&amp;rft_id=info:doi/10.1136%2Fard.2004.033514&amp;rft_id=info:pmid/16100341&amp;rft_id=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fabstract%2F64%2F9%2F1357&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Ferrell-15"><b><a href="#cite_ref-Ferrell_15-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFerrell_PB.2C_Aitcheson_CT.2C_Pearson_GR.2C_Tan_EM1981">Ferrell PB, Aitcheson CT, Pearson GR, Tan EM (March 1981). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=370617" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=370617" rel="nofollow">Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis</a>". <i>J. Clin. Invest.</i> <b>67</b> (3): 681–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1172%2FJCI110083" class="external text" title="http://dx.doi.org/10.1172%2FJCI110083" rel="nofollow">10.1172/JCI110083</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6259207" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6259207">PMID 6259207</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seroepidemiological+study+of+relationships+between+Epstein-Barr+virus+and+rheumatoid+arthritis&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.aulast=Ferrell+PB%2C+Aitcheson+CT%2C+Pearson+GR%2C+Tan+EM&amp;rft.au=Ferrell+PB%2C+Aitcheson+CT%2C+Pearson+GR%2C+Tan+EM&amp;rft.date=March+1981&amp;rft.volume=67&amp;rft.issue=3&amp;rft.pages=681%E2%80%937&amp;rft_id=info:doi/10.1172%2FJCI110083&amp;rft_id=info:pmid/6259207&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCatalano_MA.2C_Carson_DA.2C_Slovin_SF.2C_Richman_DD.2C_Vaughan_JH1979">Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan JH (November 1979). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=411744" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=411744" rel="nofollow">Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis</a>". <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>76</b> (11): 5825–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1073%2Fpnas.76.11.5825" class="external text" title="http://dx.doi.org/10.1073%2Fpnas.76.11.5825" rel="nofollow">10.1073/pnas.76.11.5825</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/230491" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/230491">PMID 230491</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antibodies+to+Epstein-Barr+virus-determined+antigens+in+normal+subjects+and+in+patients+with+seropositive+rheumatoid+arthritis&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.aulast=Catalano+MA%2C+Carson+DA%2C+Slovin+SF%2C+Richman+DD%2C+Vaughan+JH&amp;rft.au=Catalano+MA%2C+Carson+DA%2C+Slovin+SF%2C+Richman+DD%2C+Vaughan+JH&amp;rft.date=November+1979&amp;rft.volume=76&amp;rft.issue=11&amp;rft.pages=5825%E2%80%938&amp;rft_id=info:doi/10.1073%2Fpnas.76.11.5825&amp;rft_id=info:pmid/230491&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBalandraud_N.2C_Roudier_J.2C_Roudier_C2004">Balandraud N, Roudier J, Roudier C (July 2004). "Epstein-Barr virus and rheumatoid arthritis". <i>Autoimmun Rev</i> <b>3</b> (5): 362–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.autrev.2004.02.002" class="external text" title="http://dx.doi.org/10.1016%2Fj.autrev.2004.02.002" rel="nofollow">10.1016/j.autrev.2004.02.002</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15288002" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15288002">PMID 15288002</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epstein-Barr+virus+and+rheumatoid+arthritis&amp;rft.jtitle=Autoimmun+Rev&amp;rft.aulast=Balandraud+N%2C+Roudier+J%2C+Roudier+C&amp;rft.au=Balandraud+N%2C+Roudier+J%2C+Roudier+C&amp;rft.date=July+2004&amp;rft.volume=3&amp;rft.issue=5&amp;rft.pages=362%E2%80%937&amp;rft_id=info:doi/10.1016%2Fj.autrev.2004.02.002&amp;rft_id=info:pmid/15288002&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPlenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_.27.27et_al.27.272007">Plenge RM, Seielstad M, Padyukov L, <i>et al</i> (September 2007). "TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study". <i>N. Engl. J. Med.</i> <b>357</b> (12): 1199–209. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa073491" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa073491" rel="nofollow">10.1056/NEJMoa073491</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17804836" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17804836">PMID 17804836</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=TRAF1-C5+as+a+risk+locus+for+rheumatoid+arthritis--a+genomewide+study&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Plenge+RM%2C+Seielstad+M%2C+Padyukov+L%2C+%27%27et+al%27%27&amp;rft.au=Plenge+RM%2C+Seielstad+M%2C+Padyukov+L%2C+%27%27et+al%27%27&amp;rft.date=September+2007&amp;rft.volume=357&amp;rft.issue=12&amp;rft.pages=1199%E2%80%93209&amp;rft_id=info:doi/10.1056%2FNEJMoa073491&amp;rft_id=info:pmid/17804836&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPadyukov_L.2C_Silva_C.2C_Stolt_P.2C_Alfredsson_L.2C_Klareskog_L2004">Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (October 2004). "A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis". <i>Arthritis Rheum.</i> <b>50</b> (10): 3085–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fart.20553" class="external text" title="http://dx.doi.org/10.1002%2Fart.20553" rel="nofollow">10.1002/art.20553</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15476204" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15476204">PMID 15476204</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+gene-environment+interaction+between+smoking+and+shared+epitope+genes+in+HLA-DR+provides+a+high+risk+of+seropositive+rheumatoid+arthritis&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.aulast=Padyukov+L%2C+Silva+C%2C+Stolt+P%2C+Alfredsson+L%2C+Klareskog+L&amp;rft.au=Padyukov+L%2C+Silva+C%2C+Stolt+P%2C+Alfredsson+L%2C+Klareskog+L&amp;rft.date=October+2004&amp;rft.volume=50&amp;rft.issue=10&amp;rft.pages=3085%E2%80%9392&amp;rft_id=info:doi/10.1002%2Fart.20553&amp;rft_id=info:pmid/15476204&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBoland_EW.2C_Headley_NE1951">Boland EW, Headley NE (June 1951). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1520676" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1520676" rel="nofollow">Results of long-continued cortisone administration in rheumatoid arthritis</a>". <i>Calif Med</i> <b>74</b> (6): 416–423.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Results+of+long-continued+cortisone+administration+in+rheumatoid+arthritis&amp;rft.jtitle=Calif+Med&amp;rft.aulast=Boland+EW%2C+Headley+NE&amp;rft.au=Boland+EW%2C+Headley+NE&amp;rft.date=June+1951&amp;rft.volume=74&amp;rft.issue=6&amp;rft.pages=416%E2%80%93423&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFO.27Dell_J2004">O'Dell J (2004). "Therapeutic strategies for rheumatoid arthritis.". <i>N Engl J Med</i> <b>350</b> (25): 2591–602. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMra040226" class="external text" title="http://dx.doi.org/10.1056%2FNEJMra040226" rel="nofollow">10.1056/NEJMra040226</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15201416" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15201416">PMID 15201416</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Therapeutic+strategies+for+rheumatoid+arthritis.&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=O%27Dell+J&amp;rft.au=O%27Dell+J&amp;rft.date=2004&amp;rft.volume=350&amp;rft.issue=25&amp;rft.pages=2591%E2%80%93602&amp;rft_id=info:doi/10.1056%2FNEJMra040226&amp;rft_id=info:pmid/15201416&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHasler_P2006">Hasler P (June 2006). "Biological therapies directed against cells in autoimmune disease.". <i>Springer Semin Immunopathol</i> <b>27</b> (4): 443–56. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00281-006-0013-8" class="external text" title="http://dx.doi.org/10.1007%2Fs00281-006-0013-8" rel="nofollow">10.1007/s00281-006-0013-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16738955" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16738955">PMID 16738955</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Biological+therapies+directed+against+cells+in+autoimmune+disease.&amp;rft.jtitle=Springer+Semin+Immunopathol&amp;rft.aulast=Hasler+P&amp;rft.au=Hasler+P&amp;rft.date=June+2006&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=443%E2%80%9356&amp;rft_id=info:doi/10.1007%2Fs00281-006-0013-8&amp;rft_id=info:pmid/16738955&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVital_E.2C_Emery_P2005">Vital E, Emery P (Sep 15 2005). "<a href="http://www.aafp.org/afp/20050915/editorials.html" class="external text" title="http://www.aafp.org/afp/20050915/editorials.html" rel="nofollow">Advances in the treatment of early rheumatoid arthritis.</a>". <i>Am Fam Physician</i> <b>72</b> (6): 1002, 1004. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16190499" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16190499">PMID 16190499</a><span class="printonly">. <a href="http://www.aafp.org/afp/20050915/editorials.html" class="external free" title="http://www.aafp.org/afp/20050915/editorials.html" rel="nofollow">http://www.aafp.org/afp/20050915/editorials.html</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Advances+in+the+treatment+of+early+rheumatoid+arthritis.&amp;rft.jtitle=Am+Fam+Physician&amp;rft.aulast=Vital+E%2C+Emery+P&amp;rft.au=Vital+E%2C+Emery+P&amp;rft.date=Sep+15+2005&amp;rft.volume=72&amp;rft.issue=6&amp;rft.pages=1002%2C+1004&amp;rft_id=info:pmid/16190499&amp;rft_id=http%3A%2F%2Fwww.aafp.org%2Fafp%2F20050915%2Feditorials.html&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFEdwards_J.2C_Szczepanski_L.2C_Szechinski_J.2C_Filipowicz-Sosnowska_A.2C_Emery_P.2C_Close_D.2C_Stevens_R.2C_Shaw_T2004">Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D, Stevens R, Shaw T (2004). "Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.". <i>N Engl J Med</i> <b>350</b> (25): 2572–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa032534" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa032534" rel="nofollow">10.1056/NEJMoa032534</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15201414" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15201414">PMID 15201414</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+B-cell-targeted+therapy+with+rituximab+in+patients+with+rheumatoid+arthritis.&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Edwards+J%2C+Szczepanski+L%2C+Szechinski+J%2C+Filipowicz-Sosnowska+A%2C+Emery+P%2C+Close+D%2C+Stevens+R%2C+Shaw+T&amp;rft.au=Edwards+J%2C+Szczepanski+L%2C+Szechinski+J%2C+Filipowicz-Sosnowska+A%2C+Emery+P%2C+Close+D%2C+Stevens+R%2C+Shaw+T&amp;rft.date=2004&amp;rft.volume=350&amp;rft.issue=25&amp;rft.pages=2572%E2%80%9381&amp;rft_id=info:doi/10.1056%2FNEJMoa032534&amp;rft_id=info:pmid/15201414&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> Fresenius HemoCare, Inc., "New Hope for Rheumatoid Arthritis Patients," press release, September 17, 1999.</li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHart_FD1976">Hart FD (March 1976). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1639217" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1639217" rel="nofollow">History of the treatment of rheumatoid arthritis</a>". <i>Br Med J</i> <b>1</b> (6012): 763–5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/177148" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/177148">PMID 177148</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=History+of+the+treatment+of+rheumatoid+arthritis&amp;rft.jtitle=Br+Med+J&amp;rft.aulast=Hart+FD&amp;rft.au=Hart+FD&amp;rft.date=March+1976&amp;rft.volume=1&amp;rft.issue=6012&amp;rft.pages=763%E2%80%935&amp;rft_id=info:pmid/177148&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFranke_A.2C_Reiner_L.2C_Pratzel_HG.2C_Franke_T.2C_Resch_KL2000">Franke A, Reiner L, Pratzel HG, Franke T, Resch KL (August 2000). "<a href="http://rheumatology.oxfordjournals.org/cgi/content/full/39/8/894" class="external text" title="http://rheumatology.oxfordjournals.org/cgi/content/full/39/8/894" rel="nofollow">Long-term efficacy of radon spa therapy in rheumatoid arthritis--a randomized, sham-controlled study and follow-up</a>". <i>Rheumatology (Oxford)</i> <b>39</b> (8): 894–902. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Frheumatology%2F39.8.894" class="external text" title="http://dx.doi.org/10.1093%2Frheumatology%2F39.8.894" rel="nofollow">10.1093/rheumatology/39.8.894</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10952746" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10952746">PMID 10952746</a><span class="printonly">. <a href="http://rheumatology.oxfordjournals.org/cgi/content/full/39/8/894" class="external free" title="http://rheumatology.oxfordjournals.org/cgi/content/full/39/8/894" rel="nofollow">http://rheumatology.oxfordjournals.org/cgi/content/full/39/8/894</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term+efficacy+of+radon+spa+therapy+in+rheumatoid+arthritis--a+randomized%2C+sham-controlled+study+and+follow-up&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.aulast=Franke+A%2C+Reiner+L%2C+Pratzel+HG%2C+Franke+T%2C+Resch+KL&amp;rft.au=Franke+A%2C+Reiner+L%2C+Pratzel+HG%2C+Franke+T%2C+Resch+KL&amp;rft.date=August+2000&amp;rft.volume=39&amp;rft.issue=8&amp;rft.pages=894%E2%80%93902&amp;rft_id=info:doi/10.1093%2Frheumatology%2F39.8.894&amp;rft_id=info:pmid/10952746&amp;rft_id=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Ffull%2F39%2F8%2F894&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFS._Wright.2C_M._Ware_and_G._Guy2006">S. Wright, M. Ware and G. Guy (2006). "<a href="http://rheumatology.oxfordjournals.org/cgi/content/full/45/6/781" class="external text" title="http://rheumatology.oxfordjournals.org/cgi/content/full/45/6/781" rel="nofollow">The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis (LTE)</a>". <i>Rheumatology (Oxford)</i> <b>45</b>: 781. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Frheumatology%2Fkel114" class="external text" title="http://dx.doi.org/10.1093%2Frheumatology%2Fkel114" rel="nofollow">10.1093/rheumatology/kel114</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16621924" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16621924">PMID 16621924</a><span class="printonly">. <a href="http://rheumatology.oxfordjournals.org/cgi/content/full/45/6/781" class="external free" title="http://rheumatology.oxfordjournals.org/cgi/content/full/45/6/781" rel="nofollow">http://rheumatology.oxfordjournals.org/cgi/content/full/45/6/781</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+use+of+a+cannabis-based+medicine+%28Sativex%29+in+the+treatment+of+pain+caused+by+rheumatoid+arthritis+%28LTE%29&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.aulast=S.+Wright%2C+M.+Ware+and+G.+Guy&amp;rft.au=S.+Wright%2C+M.+Ware+and+G.+Guy&amp;rft.date=2006&amp;rft.volume=45&amp;rft.pages=781&amp;rft_id=info:doi/10.1093%2Frheumatology%2Fkel114&amp;rft_id=info:pmid/16621924&amp;rft_id=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Ffull%2F45%2F6%2F781&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLee1_MS.2C_Shin_B-C.2C_Ernst_E2008">Lee1 MS, Shin B-C, Ernst E (2008). "Acupuncture for rheumatoid arthritis: a systematic review". <i>Rheumatology</i> <b>47</b>: 1747–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Frheumatology%2Fken330" class="external text" title="http://dx.doi.org/10.1093%2Frheumatology%2Fken330" rel="nofollow">10.1093/rheumatology/ken330</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18710899" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18710899">PMID 18710899</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acupuncture+for+rheumatoid+arthritis%3A+a+systematic+review&amp;rft.jtitle=Rheumatology&amp;rft.aulast=Lee1+MS%2C+Shin+B-C%2C+Ernst+E&amp;rft.au=Lee1+MS%2C+Shin+B-C%2C+Ernst+E&amp;rft.date=2008&amp;rft.volume=47&amp;rft.pages=1747%26ndash%3B53&amp;rft_id=info:doi/10.1093%2Frheumatology%2Fken330&amp;rft_id=info:pmid/18710899&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> <a href="http://www.rheumatoid.org.uk/article.php?article_id=112" class="external text" title="http://www.rheumatoid.org.uk/article.php?article_id=112" rel="nofollow">Excess mortality in rheumatoid arthritis</a></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <a href="http://www.mayoclinic.org/news2005-rst/2654.html" class="external text" title="http://www.mayoclinic.org/news2005-rst/2654.html" rel="nofollow">The second largest contributor of mortality is cerebrovascular disease. Increased risk of heart disease in rheumatoid arthritis patients</a></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> <a href="http://www.hopkins-arthritis.org/news-archive/2002/cardiac.html" class="external text" title="http://www.hopkins-arthritis.org/news-archive/2002/cardiac.html" rel="nofollow">Cardiac disease in rheumatoid arthritis</a></li>
<li id="cite_note-pmid17045630-33"><b><a href="#cite_ref-pmid17045630_33-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlamanos_Y.2C_Voulgari_PV.2C_Drosos_AA2006">Alamanos Y, Voulgari PV, Drosos AA (2006). "Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review". <i>Semin. Arthritis Rheum.</i> <b>36</b> (3): 182–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.semarthrit.2006.08.006" class="external text" title="http://dx.doi.org/10.1016%2Fj.semarthrit.2006.08.006" rel="nofollow">10.1016/j.semarthrit.2006.08.006</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17045630" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17045630">PMID 17045630</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Incidence+and+prevalence+of+rheumatoid+arthritis%2C+based+on+the+1987+American+College+of+Rheumatology+criteria%3A+a+systematic+review&amp;rft.jtitle=Semin.+Arthritis+Rheum.&amp;rft.aulast=Alamanos+Y%2C+Voulgari+PV%2C+Drosos+AA&amp;rft.au=Alamanos+Y%2C+Voulgari+PV%2C+Drosos+AA&amp;rft.date=2006&amp;rft.volume=36&amp;rft.issue=3&amp;rft.pages=182%E2%80%938&amp;rft_id=info:doi/10.1016%2Fj.semarthrit.2006.08.006&amp;rft_id=info:pmid/17045630&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <a href="http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm" class="external free" title="http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm" rel="nofollow">http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm</a> Tennessee Origins of Rheumatoid Arthritis</li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <a href="http://www.arc.org.uk/newsviews/arctdy/104/bones.htm" class="external free" title="http://www.arc.org.uk/newsviews/arctdy/104/bones.htm" rel="nofollow">http://www.arc.org.uk/newsviews/arctdy/104/bones.htm</a> Bones of Contention</li>
<li id="cite_note-pmid14528501-36"><b><a href="#cite_ref-pmid14528501_36-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRothschild_BM.2C_Rothschild_C.2C_Helbling_M2003">Rothschild BM, Rothschild C, Helbling M (2003). "Unified theory of the origins of erosive arthritis: conditioning as a protective/directing mechanism?". <i>J. Rheumatol.</i> <b>30</b> (10): 2095–102. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14528501" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14528501">PMID 14528501</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Unified+theory+of+the+origins+of+erosive+arthritis%3A+conditioning+as+a+protective%2Fdirecting+mechanism%3F&amp;rft.jtitle=J.+Rheumatol.&amp;rft.aulast=Rothschild+BM%2C+Rothschild+C%2C+Helbling+M&amp;rft.au=Rothschild+BM%2C+Rothschild+C%2C+Helbling+M&amp;rft.date=2003&amp;rft.volume=30&amp;rft.issue=10&amp;rft.pages=2095%E2%80%93102&amp;rft_id=info:pmid/14528501&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <a href="http://media.www.michigandaily.com/media/storage/paper851/news/2005/02/01/News/Scientist.Finds.Surprising.Links.Between.Arthritis.And.Tuberculosis-1428389.shtml?sourcedomain=www.michigandaily.com&amp;MIIHost=media.collegepublisher.com" class="external text" title="http://media.www.michigandaily.com/media/storage/paper851/news/2005/02/01/News/Scientist.Finds.Surprising.Links.Between.Arthritis.And.Tuberculosis-1428389.shtml?sourcedomain=www.michigandaily.com&amp;MIIHost=media.collegepublisher.com" rel="nofollow">Scientist finds surprising links between arthritis and tuberculosis</a></li>
<li id="cite_note-pmid7005475-38"><b><a href="#cite_ref-pmid7005475_38-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAppelboom_T.2C_de_Boelpaepe_C.2C_Ehrlich_GE.2C_Famaey_JP1981">Appelboom T, de Boelpaepe C, Ehrlich GE, Famaey JP (1981). "Rubens and the question of antiquity of rheumatoid arthritis". <i>JAMA</i> <b>245</b> (5): 483–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.245.5.483" class="external text" title="http://dx.doi.org/10.1001%2Fjama.245.5.483" rel="nofollow">10.1001/jama.245.5.483</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7005475" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7005475">PMID 7005475</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rubens+and+the+question+of+antiquity+of+rheumatoid+arthritis&amp;rft.jtitle=JAMA&amp;rft.aulast=Appelboom+T%2C+de+Boelpaepe+C%2C+Ehrlich+GE%2C+Famaey+JP&amp;rft.au=Appelboom+T%2C+de+Boelpaepe+C%2C+Ehrlich+GE%2C+Famaey+JP&amp;rft.date=1981&amp;rft.volume=245&amp;rft.issue=5&amp;rft.pages=483%E2%80%936&amp;rft_id=info:doi/10.1001%2Fjama.245.5.483&amp;rft_id=info:pmid/7005475&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> <a href="http://japan.medscape.com/viewarticle/538251" class="external free" title="http://japan.medscape.com/viewarticle/538251" rel="nofollow">http://japan.medscape.com/viewarticle/538251</a> Did RA travel from New World to Old? The Rubens connection</li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDequeker_J..2C_Rico_H.1992">Dequeker J., Rico H. (1992). "Rheumatoid arthritis-like deformities in an early 16th-century painting of the Flemish-Dutch school". <i>JAMA</i> <b>268</b>: 249–251. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.268.2.249" class="external text" title="http://dx.doi.org/10.1001%2Fjama.268.2.249" rel="nofollow">10.1001/jama.268.2.249</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1608144" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1608144">PMID 1608144</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rheumatoid+arthritis-like+deformities+in+an+early+16th-century+painting+of+the+Flemish-Dutch+school&amp;rft.jtitle=JAMA&amp;rft.aulast=Dequeker+J.%2C+Rico+H.&amp;rft.au=Dequeker+J.%2C+Rico+H.&amp;rft.date=1992&amp;rft.volume=268&amp;rft.pages=249%E2%80%93251&amp;rft_id=info:doi/10.1001%2Fjama.268.2.249&amp;rft_id=info:pmid/1608144&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFGarrod_AB1859">Garrod AB (1859). <i>The Nature and Treatment of Gout and Rheumatic Gout</i>. London: Walton and Maberly.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Nature+and+Treatment+of+Gout+and+Rheumatic+Gout&amp;rft.aulast=Garrod+AB&amp;rft.au=Garrod+AB&amp;rft.date=1859&amp;rft.place=London&amp;rft.pub=Walton+and+Maberly&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-42"><b><a href="#cite_ref-42" title="">^</a></b> <cite style="font-style:normal" class="news"><a href="http://seattlepi.nwsource.com/business/113804_theinsider24.shtml" class="external text" title="http://seattlepi.nwsource.com/business/113804_theinsider24.shtml" rel="nofollow">"The Insider: Amgen recruits high-flier to help Enbrel sales take off"</a>. <a href="/wiki/Seattle_Post-Intelligencer" title="Seattle Post-Intelligencer">Seattle Post-Intelligencer</a>. <span class="mw-formatted-date" title="2007-11-07"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/November_7" title="November 7">11-07</a></span><span class="printonly">. <a href="http://seattlepi.nwsource.com/business/113804_theinsider24.shtml" class="external free" title="http://seattlepi.nwsource.com/business/113804_theinsider24.shtml" rel="nofollow">http://seattlepi.nwsource.com/business/113804_theinsider24.shtml</a></span><span class="reference-accessdate">. Retrieved on 2003-03-24</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=The+Insider%3A+Amgen+recruits+high-flier+to+help+Enbrel+sales+take+off&amp;rft.atitle=&amp;rft.date=%5B%5B2007-11-07%5D%5D&amp;rft.pub=%5B%5BSeattle+Post-Intelligencer%5D%5D&amp;rft_id=http%3A%2F%2Fseattlepi.nwsource.com%2Fbusiness%2F113804_theinsider24.shtml&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://findarticles.com/p/articles/mi_pwwi/is_200308/ai_mark654573218" class="external text" title="http://findarticles.com/p/articles/mi_pwwi/is_200308/ai_mark654573218" rel="nofollow">""Sopranos" Star Aida Turturro Brings Rheumatoid Arthritis Awareness Campaign to Philadelphia"</a><span class="printonly">. <a href="http://findarticles.com/p/articles/mi_pwwi/is_200308/ai_mark654573218" class="external free" title="http://findarticles.com/p/articles/mi_pwwi/is_200308/ai_mark654573218" rel="nofollow">http://findarticles.com/p/articles/mi_pwwi/is_200308/ai_mark654573218</a></span><span class="reference-accessdate">. Retrieved on 2007-12-18</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=%22Sopranos%22+Star+Aida+Turturro+Brings+Rheumatoid+Arthritis+Awareness+Campaign+to+Philadelphia&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Ffindarticles.com%2Fp%2Farticles%2Fmi_pwwi%2Fis_200308%2Fai_mark654573218&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=29" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><cite style="font-style:normal" class="web"><a href="http://www.withinourreach.info" class="external text" title="http://www.withinourreach.info" rel="nofollow">"Within Our Reach: Finding a Cure for Rheumatoid Arthritis"</a>. The only $30 million campaign that specifically funds RA research - American College of Rheumatology Research and Education Foundation<span class="printonly">. <a href="http://www.withinourreach.info" class="external free" title="http://www.withinourreach.info" rel="nofollow">http://www.withinourreach.info</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Within+Our+Reach%3A+Finding+a+Cure+for+Rheumatoid+Arthritis&amp;rft.atitle=&amp;rft.pub=The+only+%2430+million+campaign+that+specifically+funds+RA+research+-+American+College+of+Rheumatology+Research+and+Education+Foundation&amp;rft_id=http%3A%2F%2Fwww.withinourreach.info&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li><a href="http://www.dmoz.org/Health/Conditions_and_Diseases/Musculoskeletal_Disorders/Arthritis/Rheumatoid/" class="external text" title="http://www.dmoz.org/Health/Conditions_and_Diseases/Musculoskeletal_Disorders/Arthritis/Rheumatoid/" rel="nofollow">Rheumatoid arthritis</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><cite style="font-style:normal" class="web"><a href="http://www.arthritis.org/conditions/DiseaseCenter/RA/default.asp" class="external text" title="http://www.arthritis.org/conditions/DiseaseCenter/RA/default.asp" rel="nofollow">"Rheumatoid Arthritis"</a>. Arthritis Foundation<span class="printonly">. <a href="http://www.arthritis.org/conditions/DiseaseCenter/RA/default.asp" class="external free" title="http://www.arthritis.org/conditions/DiseaseCenter/RA/default.asp" rel="nofollow">http://www.arthritis.org/conditions/DiseaseCenter/RA/default.asp</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Rheumatoid+Arthritis&amp;rft.atitle=&amp;rft.pub=Arthritis+Foundation&amp;rft_id=http%3A%2F%2Fwww.arthritis.org%2Fconditions%2FDiseaseCenter%2FRA%2Fdefault.asp&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li><cite style="font-style:normal" class="web"><a href="http://www.arc.org.uk/arthinfo/patpubs/6033/6033.asp" class="external text" title="http://www.arc.org.uk/arthinfo/patpubs/6033/6033.asp" rel="nofollow">"Rheumatoid Arthritis"</a>. Arthritis Research Campaign<span class="printonly">. <a href="http://www.arc.org.uk/arthinfo/patpubs/6033/6033.asp" class="external free" title="http://www.arc.org.uk/arthinfo/patpubs/6033/6033.asp" rel="nofollow">http://www.arc.org.uk/arthinfo/patpubs/6033/6033.asp</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Rheumatoid+Arthritis&amp;rft.atitle=&amp;rft.pub=Arthritis+Research+Campaign&amp;rft_id=http%3A%2F%2Fwww.arc.org.uk%2Farthinfo%2Fpatpubs%2F6033%2F6033.asp&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li><cite style="font-style:normal" class="web" id="CITEREFCharles_Weber">Charles Weber. <a href="http://charles_w.tripod.com/arthritis2.html" class="external text" title="http://charles_w.tripod.com/arthritis2.html" rel="nofollow">"History of rheumatoid arthritis"</a><span class="printonly">. <a href="http://charles_w.tripod.com/arthritis2.html" class="external free" title="http://charles_w.tripod.com/arthritis2.html" rel="nofollow">http://charles_w.tripod.com/arthritis2.html</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=History+of+rheumatoid+arthritis&amp;rft.atitle=&amp;rft.aulast=Charles+Weber&amp;rft.au=Charles+Weber&amp;rft_id=http%3A%2F%2Fcharles_w.tripod.com%2Farthritis2.html&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
<li><cite style="font-style:normal" class="web"><a href="http://www.rheumatoid.org.uk/" class="external text" title="http://www.rheumatoid.org.uk/" rel="nofollow">"UK National Rheumatoid Arthritis Society"</a><span class="printonly">. <a href="http://www.rheumatoid.org.uk/" class="external free" title="http://www.rheumatoid.org.uk/" rel="nofollow">http://www.rheumatoid.org.uk/</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=UK+National+Rheumatoid+Arthritis+Society&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.rheumatoid.org.uk%2F&amp;rfr_id=info:sid/en.wikipedia.org:Rheumatoid_arthritis"><span style="display: none;">&#160;</span></span></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Arthropathies_and_related_conditions" title="Template:Arthropathies and related conditions"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Arthropathies_and_related_conditions&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Arthropathies and related conditions (page does not exist)"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Arthropathies_and_related_conditions&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Arthropathies_and_related_conditions&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Musculoskeletal_disorders" title="Musculoskeletal disorders">Musculoskeletal disorders</a>: <a href="/wiki/Arthropathy" title="Arthropathy">Arthropathies</a> (<a href="/wiki/ICD-10_Chapter_XIII:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#.28M00-M25.29_Arthropathies" title="ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue">M00-M19</a>, <a href="/wiki/List_of_ICD-9_codes_710-739:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#arthropathies_and_related_disorders_.28710-719.29" title="List of ICD-9 codes 710-739: Diseases of the musculoskeletal system and connective tissue" class="mw-redirect">711-719</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: Linen;"><a href="/wiki/Arthritis" title="Arthritis">Arthritis</a><br />
(<a href="/wiki/Monoarthritis" title="Monoarthritis">monoarthritis</a>/<br />
<a href="/wiki/Polyarthritis" title="Polyarthritis">polyarthritis</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a><br />
(<a href="/wiki/Neutrophilia" title="Neutrophilia">Neutrophilia</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;"><a href="/wiki/Infectious_arthritis" title="Infectious arthritis" class="mw-redirect">Infectious</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Septic_arthritis" title="Septic arthritis">Septic arthritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tuberculosis_arthritis" title="Tuberculosis arthritis" class="mw-redirect">Tuberculosis arthritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a> (indirectly)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;">Noninfectious</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Seronegative_spondyloarthropathy" title="Seronegative spondyloarthropathy">Seronegative spondyloarthropathy</a>:</i> <a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">Psoriatic arthritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">Ankylosing spondylitis</a>
<p><i><strong class="selflink">Rheumatoid arthritis</strong>:</i> <a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">Juvenile idiopathic arthritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Adult-onset_Still%27s_disease" title="Adult-onset Still's disease">Adult-onset Still's disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Felty%27s_syndrome" title="Felty's syndrome">Felty's syndrome</a></p>
<i><a href="/wiki/Crystal_arthropathy" title="Crystal arthropathy">Crystal arthropathy</a>:</i> <a href="/wiki/Gout" title="Gout">Gout</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Chondrocalcinosis" title="Chondrocalcinosis">Chondrocalcinosis</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;">Noninflammatory</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Osteoarthritis" title="Osteoarthritis">Osteoarthritis</a>:</i> <a href="/wiki/Heberden%27s_node" title="Heberden's node">Heberden's node</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Bouchard%27s_nodes" title="Bouchard's nodes">Bouchard's nodes</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: Linen;">Other</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Hemorrhage" title="Hemorrhage" class="mw-redirect">hemorrhage</a></i> (<a href="/wiki/Hemarthrosis" title="Hemarthrosis">Hemarthrosis</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Pain" title="Pain">pain</a></i> (<a href="/wiki/Arthralgia" title="Arthralgia">Arthralgia</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Osteophyte" title="Osteophyte">Osteophyte</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypermobility" title="Hypermobility">Hypermobility</a><span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Villonodular_synovitis" title="Villonodular synovitis">villonodular synovitis</a></i> (<a href="/wiki/Pigmented_villonodular_synovitis" title="Pigmented villonodular synovitis">Pigmented villonodular synovitis</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>see also <a href="/wiki/Template:Congenital_malformations_and_deformations_of_musculoskeletal_system" title="Template:Congenital malformations and deformations of musculoskeletal system">congenital</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Hypersensitivity_and_autoimmune_diseases" title="Template talk:Hypersensitivity and autoimmune diseases"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_and_autoimmune_diseases&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_and_autoimmune_diseases&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Immune_disorder" title="Immune disorder">Immune disorders</a>: <a href="/wiki/Hypersensitivity" title="Hypersensitivity">Hypersensitivity</a> and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_I_hypersensitivity" title="Type I hypersensitivity">Type I</a>/<a href="/wiki/Allergy" title="Allergy">allergy</a>/<a href="/wiki/Atopy" title="Atopy">atopy</a><br />
(<a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgE</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Atopic_dermatitis" title="Atopic dermatitis">Atopic dermatitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Urticaria" title="Urticaria">Allergic urticaria</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hay_fever" title="Hay fever" class="mw-redirect">Hay fever</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Asthma" title="Asthma">Allergic asthma</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Anaphylaxis" title="Anaphylaxis">Anaphylaxis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Food_allergy" title="Food allergy">Food allergy</a> (<a href="/wiki/Milk_allergy" title="Milk allergy">Milk</a>, <a href="/wiki/Egg_allergy" title="Egg allergy">Egg</a>, <a href="/wiki/Peanut_allergy" title="Peanut allergy">Peanut</a>, <a href="/wiki/Tree_nut_allergy" title="Tree nut allergy">Tree nut</a>, <a href="/wiki/Seafood_allergy" title="Seafood allergy">Seafood</a>, <a href="/wiki/Soy_allergy" title="Soy allergy">Soy</a>, <a href="/wiki/Wheat_allergy" title="Wheat allergy">Wheat</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>none</i></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_II_hypersensitivity" title="Type II hypersensitivity">Type II</a>/<a href="/wiki/Antibody-dependent_cell-mediated_cytotoxicity" title="Antibody-dependent cell-mediated cytotoxicity">ADCC</a><br />
(<a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a>, <a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgG</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Penicillin_allergy" title="Penicillin allergy" class="mw-redirect">Penicillin allergy</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Cytotoxic" title="Cytotoxic" class="mw-redirect">Cytotoxic</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune hemolytic anemia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Idiopathic_thrombocytopenic_purpura" title="Idiopathic thrombocytopenic purpura">Idiopathic thrombocytopenic purpura</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Bullous_pemphigoid" title="Bullous pemphigoid">Bullous pemphigoid</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pemphigus_vulgaris" title="Pemphigus vulgaris">Pemphigus vulgaris</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Goodpasture%27s_syndrome" title="Goodpasture's syndrome">Goodpasture's syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">"<a href="/wiki/Hypersensitivity#Type_5" title="Hypersensitivity">Type 5</a>"/<a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III</a><br />
(<a href="/wiki/Immune_complex" title="Immune complex">Immune complex</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Henoch-Sch%C3%B6nlein_purpura" title="Henoch-Schönlein purpura">Henoch-Schönlein purpura</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypersensitivity_vasculitis" title="Hypersensitivity vasculitis">Hypersensitivity vasculitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a><span style="font-weight:bold;">&#160;·</span> <strong class="selflink">Rheumatoid arthritis</strong><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Farmer%27s_lung" title="Farmer's lung">Farmer's lung</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Post-streptococcal_glomerulonephritis" title="Post-streptococcal glomerulonephritis">Post-streptococcal glomerulonephritis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Serum_sickness" title="Serum sickness">Serum sickness</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Arthus_reaction" title="Arthus reaction">Arthus reaction</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">Type IV</a>/<a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">cell-mediated</a><br />
(<a href="/wiki/T-cells" title="T-cells" class="mw-redirect">T-cells</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Contact_dermatitis" title="Contact dermatitis">Contact dermatitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Mantoux_test" title="Mantoux test">Mantoux test</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">Diabetes mellitus type 1</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's thyroiditis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Guillain-Barr%C3%A9_syndrome" title="Guillain-Barré syndrome">Guillain-Barré syndrome</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Giant_cell_arteritis" title="Giant cell arteritis">Giant cell arteritis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Graft-versus-host_disease" title="Graft-versus-host disease">GVHD</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Transfusion-associated_graft_versus_host_disease" title="Transfusion-associated graft versus host disease">Transfusion-associated graft versus host disease</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;">Unknown/<br />
multiple</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Foreign</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a> (<a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">Allergic bronchopulmonary aspergillosis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Transplant_rejection" title="Transplant rejection">Transplant rejection</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Latex_allergy" title="Latex allergy">Latex allergy</a> (I+IV)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Autoimmune</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a> (<a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a>, <a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_adrenalitis" title="Autoimmune adrenalitis">Autoimmune adrenalitis</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 24015/1000000
Post-expand include size: 278902/2048000 bytes
Template argument size: 120858/2048000 bytes
Expensive parser function count: 14/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:25875-0!1!0!default!!en!2 and timestamp 20090411170955 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Rheumatoid_arthritis">http://en.wikipedia.org/wiki/Rheumatoid_arthritis</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Connective_tissue_diseases" title="Category:Connective tissue diseases">Connective tissue diseases</a></span> | <span dir='ltr'><a href="/wiki/Category:Arthritis" title="Category:Arthritis">Arthritis</a></span> | <span dir='ltr'><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></span> | <span dir='ltr'><a href="/wiki/Category:Diseases_involving_the_fasciae" title="Category:Diseases involving the fasciae">Diseases involving the fasciae</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_July_2008" title="Category:Articles with unsourced statements since July 2008">Articles with unsourced statements since July 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_August_2008" title="Category:Articles with unsourced statements since August 2008">Articles with unsourced statements since August 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_needing_additional_references_from_October_2008" title="Category:Articles needing additional references from October 2008">Articles needing additional references from October 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2009" title="Category:Articles with unsourced statements since February 2009">Articles with unsourced statements since February 2009</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Rheumatoid_arthritis" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Rheumatoid_arthritis" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Rheumatoid_arthritis" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Rheumatoid_arthritis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Rheumatoid_arthritis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;oldid=283205273" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Rheumatoid_arthritis&amp;id=283205273">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%A7%D9%84%D9%85%D9%81%D8%A7%D8%B5%D9%84_%D8%A7%D9%84%D8%B1%D8%AB%D9%8A%D8%A7%D9%86%D9%8A">العربية</a></li>
				<li class="interwiki-bs"><a href="http://bs.wikipedia.org/wiki/Reumatoidni_artritis">Bosanski</a></li>
				<li class="interwiki-ca"><a href="http://ca.wikipedia.org/wiki/Artritis_reumatoide">Català</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Revmatoidn%C3%AD_artritida">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Leddegigt">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Rheumatoide_Arthritis">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Artritis_reumatoide">Español</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D8%A2%D8%B1%D8%AA%D8%B1%DB%8C%D8%AA_%D8%B1%D9%88%D9%85%D8%A7%D8%AA%D9%88%D8%A6%DB%8C%D8%AF">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Polyarthrite_rhumato%C3%AFde">Français</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Rheumatoid_arthritis">Bahasa Indonesia</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Artrite_reumatoide">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%93%D7%9C%D7%A7%D7%AA_%D7%9E%D7%A4%D7%A8%D7%A7%D7%99%D7%9D_%D7%A9%D7%99%D7%92%D7%A8%D7%95%D7%A0%D7%99%D7%AA">עברית</a></li>
				<li class="interwiki-ku"><a href="http://ku.wikipedia.org/wiki/Artr%C3%AEta_rumato%C3%AEd">Kurdî / كوردی</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Reumato%C3%AFde_artritis">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E9%96%A2%E7%AF%80%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81">日本語</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Reumatoidalne_zapalenie_staw%C3%B3w">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Artrite_reumatoide">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%BD%D1%8B%D0%B9_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82">Русский</a></li>
				<li class="interwiki-sr"><a href="http://sr.wikipedia.org/wiki/%D0%A0%D0%B5%D1%83%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%BD%D0%B8_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82%D0%B8%D1%81">Српски / Srpski</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Nivelreuma">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Reumatoid_artrit">Svenska</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Romatoid_artrit">Türkçe</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E9%A1%9E%E9%A2%A8%E6%BF%95%E6%80%A7%E9%97%9C%E7%AF%80%E7%82%8E">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 11 April 2009, at 17:09 (UTC).</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv168 in 0.065 secs. --></body></html>
